Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Sammenligning af Tiotropium i HandiHaler versus Respimat ved kronisk obstruktiv lungesygdom

20. maj 2014 opdateret af: Boehringer Ingelheim

Et randomiseret, aktivt kontrolleret, dobbeltblindt, dobbelt-dummy, parallelt gruppedesign, multicenterforsøg for at sammenligne effektiviteten og sikkerheden af ​​2,5 µg og 5 µg Tiotropium-inhalationsopløsning leveret af Respimat-inhalatoren med Tiotropium-inhalationskapsler 18 µg leveret af HandiHaler (TIOSPIR)

Direkte sammenligningsundersøgelser af tiotropium HandiHaler® 18 µg og Respimat® 5 µg formuleringer har været begrænset til 4-ugers crossover undersøgelser. Derfor kræves prospektive data fra et forsøg af passende størrelse og varighed for at fastslå, at tiotropium Respimat® sammenlignet med tiotropium HandiHaler® vil have (a) lignende virkninger på sikkerheden og (b) lignende eller overlegne virkninger på eksacerbationer.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

17183

Fase

  • Fase 3

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Argentina
      • Capital Federal, Argentina
        • 205.452.54003 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 205.452.54011 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 205.452.54013 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 205.452.54027 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 205.452.54029 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 205.452.54031 Boehringer Ingelheim Investigational Site
      • Florencio Varela, Argentina
        • 205.452.54025 Boehringer Ingelheim Investigational Site
      • Mar del Plata, Argentina
        • 205.452.54007 Boehringer Ingelheim Investigational Site
      • Mar del Plata, Argentina
        • 205.452.54015 Boehringer Ingelheim Investigational Site
      • Mendoza, Argentina
        • 205.452.54001 Boehringer Ingelheim Investigational Site
      • Monte Grande, Argentina
        • 205.452.54019 Boehringer Ingelheim Investigational Site
      • Quilmes, Argentina
        • 205.452.54005 Boehringer Ingelheim Investigational Site
      • Rosario, Argentina
        • 205.452.54009 Boehringer Ingelheim Investigational Site
      • Rosario, Argentina
        • 205.452.54021 Boehringer Ingelheim Investigational Site
      • San Miguel de Tucumán, Argentina
        • 205.452.54017 Boehringer Ingelheim Investigational Site
      • San Miguel de Tucumán, Argentina
        • 205.452.54023 Boehringer Ingelheim Investigational Site
  • Australien
    • South Australia
      • Adelaide, South Australia, Australien
        • 205.452.61006 Boehringer Ingelheim Investigational Site
      • Woodville, South Australia, Australien
        • 205.452.61002 Boehringer Ingelheim Investigational Site
    • Victoria
      • Box Hill, Victoria, Australien
        • 205.452.61004 Boehringer Ingelheim Investigational Site
      • Footscray, Victoria, Australien
        • 205.452.61003 Boehringer Ingelheim Investigational Site
      • Frankston, Victoria, Australien
        • 205.452.61001 Boehringer Ingelheim Investigational Site
    • Western Australia
      • Nedlands, Western Australia, Australien
        • 205.452.61005 Boehringer Ingelheim Investigational Site
  • Belgien
      • Godinne, Belgien
        • 205.452.32009 Boehringer Ingelheim Investigational Site
      • Gozée, Belgien
        • 205.452.32007 Boehringer Ingelheim Investigational Site
      • Halen, Belgien
        • 205.452.32002 Boehringer Ingelheim Investigational Site
      • Leuven, Belgien
        • 205.452.32001 Boehringer Ingelheim Investigational Site
      • Linkebeek, Belgien
        • 205.452.32006 Boehringer Ingelheim Investigational Site
      • Merksem, Belgien
        • 205.452.32005 Boehringer Ingelheim Investigational Site
      • Natoye, Belgien
        • 205.452.32008 Boehringer Ingelheim Investigational Site
      • Tessenderlo, Belgien
        • 205.452.32003 Boehringer Ingelheim Investigational Site
      • Zichem, Belgien
        • 205.452.32004 Boehringer Ingelheim Investigational Site
  • Brasilien
      • Florianópolis, Brasilien
        • 205.452.55005 Boehringer Ingelheim Investigational Site
      • Passo Fundo - RS, Brasilien
        • 205.452.55010 Boehringer Ingelheim Investigational Site
      • Porto Alegre, Brasilien
        • 205.452.55001 Boehringer Ingelheim Investigational Site
      • Porto Alegre, Brasilien
        • 205.452.55002 Boehringer Ingelheim Investigational Site
      • Recife, Brasilien
        • 205.452.55003 Boehringer Ingelheim Investigational Site
      • Rio de Janeiro, Brasilien
        • 205.452.55004 Boehringer Ingelheim Investigational Site
      • Río de Janeiro, Brasilien
        • 205.452.55011 Boehringer Ingelheim Investigational Site
      • Sao Pablo, Brasilien
        • 205.452.55008 Boehringer Ingelheim Investigational Site
      • Sao Paulo, Brasilien
        • 205.452.55009 Boehringer Ingelheim Investigational Site
      • São Paulo, Brasilien
        • 205.452.55006 Boehringer Ingelheim Investigational Site
      • São Paulo, Brasilien
        • 205.452.55007 Boehringer Ingelheim Investigational Site
  • Bulgarien
      • Plovdiv, Bulgarien
        • 205.452.35909 Boehringer Ingelheim Investigational Site
      • Plovdiv, Bulgarien
        • 205.452.35910 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 205.452.35901 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 205.452.35902 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 205.452.35903 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 205.452.35904 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 205.452.35905 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 205.452.35908 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 205.452.35914 Boehringer Ingelheim Investigational Site
      • Sofia, Bulgarien
        • 205.452.35915 Boehringer Ingelheim Investigational Site
      • Stara Zagora, Bulgarien
        • 205.452.35912 Boehringer Ingelheim Investigational Site
      • Veliko Turnovo, Bulgarien
        • 205.452.35906 Boehringer Ingelheim Investigational Site
  • Canada
      • Quebec, Canada
        • 205.452.11031 Boehringer Ingelheim Investigational Site
    • Alberta
      • Calgary, Alberta, Canada
        • 205.452.11015 Boehringer Ingelheim Investigational Site
      • Calgary, Alberta, Canada
        • 205.452.11032 Boehringer Ingelheim Investigational Site
      • Edmonton, Alberta, Canada
        • 205.452.11028 Boehringer Ingelheim Investigational Site
      • Edmonton, Alberta, Canada
        • 205.452.11037 Boehringer Ingelheim Investigational Site
      • Edmonton, Alberta, Canada
        • 205.452.11045 Boehringer Ingelheim Investigational Site
      • Edmonton, Alberta, Canada
        • 205.452.11047 Boehringer Ingelheim Investigational Site
      • Spruce Grove, Alberta, Canada
        • 205.452.11002 Boehringer Ingelheim Investigational Site
    • British Columbia
      • Kelowna, British Columbia, Canada
        • 205.452.11048 Boehringer Ingelheim Investigational Site
      • Maple Ridge, British Columbia, Canada
        • 205.452.11051 Boehringer Ingelheim Investigational Site
      • Vancouver, British Columbia, Canada
        • 205.452.11014 Boehringer Ingelheim Investigational Site
      • Vancouver, British Columbia, Canada
        • 205.452.11016 Boehringer Ingelheim Investigational Site
    • Manitoba
      • Winnipeg, Manitoba, Canada
        • 205.452.11025 Boehringer Ingelheim Investigational Site
    • New Brunswick
      • Moncton, New Brunswick, Canada
        • 205.452.11033 Boehringer Ingelheim Investigational Site
      • Saint John, New Brunswick, Canada
        • 205.452.11010 Boehringer Ingelheim Investigational Site
    • Newfoundland and Labrador
      • Grand Falls-Windsor, Newfoundland and Labrador, Canada
        • 205.452.11044 Boehringer Ingelheim Investigational Site
      • Mount Pearl, Newfoundland and Labrador, Canada
        • 205.452.11053 Boehringer Ingelheim Investigational Site
      • St. John's, Newfoundland and Labrador, Canada
        • 205.452.11017 Boehringer Ingelheim Investigational Site
      • St. John's, Newfoundland and Labrador, Canada
        • 205.452.11021 Boehringer Ingelheim Investigational Site
    • Ontario
      • Burlington, Ontario, Canada
        • 205.452.11030 Boehringer Ingelheim Investigational Site
      • Corunna, Ontario, Canada
        • 205.452.11042 Boehringer Ingelheim Investigational Site
      • Courtice, Ontario, Canada
        • 205.452.11049 Boehringer Ingelheim Investigational Site
      • Downsview, Ontario, Canada
        • 205.452.11004 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 205.452.11009 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 205.452.11029 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 205.452.11050 Boehringer Ingelheim Investigational Site
      • Kingston, Ontario, Canada
        • 205.452.11040 Boehringer Ingelheim Investigational Site
      • London, Ontario, Canada
        • 205.452.11035 Boehringer Ingelheim Investigational Site
      • Mississauga, Ontario, Canada
        • 205.452.11001 Boehringer Ingelheim Investigational Site
      • Mississauga, Ontario, Canada
        • 205.452.11054 Boehringer Ingelheim Investigational Site
      • Newmarket, Ontario, Canada
        • 205.452.11022 Boehringer Ingelheim Investigational Site
      • Ottawa, Ontario, Canada
        • 205.452.11024 Boehringer Ingelheim Investigational Site
      • Richmond Hill, Ontario, Canada
        • 205.452.11027 Boehringer Ingelheim Investigational Site
      • Sarnia, Ontario, Canada
        • 205.452.11041 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 205.452.11019 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 205.452.11034 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 205.452.11052 Boehringer Ingelheim Investigational Site
      • Windsor, Ontario, Canada
        • 205.452.11012 Boehringer Ingelheim Investigational Site
    • Quebec
      • Greenfield Park, Quebec, Canada
        • 205.452.11007 Boehringer Ingelheim Investigational Site
      • La Malbaie, Quebec, Canada
        • 205.452.11005 Boehringer Ingelheim Investigational Site
      • Longueuil, Quebec, Canada
        • 205.452.11006 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 205.452.11043 Boehringer Ingelheim Investigational Site
      • Point Claire, Quebec, Canada
        • 205.452.11013 Boehringer Ingelheim Investigational Site
      • Sherbrooke, Quebec, Canada
        • 205.452.11018 Boehringer Ingelheim Investigational Site
      • St. Lambert, Quebec, Canada
        • 205.452.11020 Boehringer Ingelheim Investigational Site
      • Trois-Rivieres, Quebec, Canada
        • 205.452.11026 Boehringer Ingelheim Investigational Site
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada
        • 205.452.11003 Boehringer Ingelheim Investigational Site
      • Saskatoon, Saskatchewan, Canada
        • 205.452.11011 Boehringer Ingelheim Investigational Site
      • Saskatoon, Saskatchewan, Canada
        • 205.452.11036 Boehringer Ingelheim Investigational Site
      • Saskatoon, Saskatchewan, Canada
        • 205.452.11039 Boehringer Ingelheim Investigational Site
  • Colombia
      • Bogotá, Colombia
        • 205.452.57002 Boehringer Ingelheim Investigational Site
      • Bogotá, Colombia
        • 205.452.57004 Boehringer Ingelheim Investigational Site
      • Bogotá, Colombia
        • 205.452.57005 Boehringer Ingelheim Investigational Site
      • Bogotá, Colombia
        • 205.452.57006 Boehringer Ingelheim Investigational Site
      • Medellín, Colombia
        • 205.452.57001 Boehringer Ingelheim Investigational Site
  • Danmark
      • Aalborg, Danmark
        • 205.452.45002 Boehringer Ingelheim Investigational Site
      • Aarhus C, Danmark
        • 205.452.45003 Boehringer Ingelheim Investigational Site
      • Birkerød, Danmark
        • 205.452.45006 Boehringer Ingelheim Investigational Site
      • Kolding, Danmark
        • 205.452.45013 Boehringer Ingelheim Investigational Site
      • København NV, Danmark
        • 205.452.45001 Boehringer Ingelheim Investigational Site
      • København S, Danmark
        • 205.452.45005 Boehringer Ingelheim Investigational Site
      • Odense C, Danmark
        • 205.452.45012 Boehringer Ingelheim Investigational Site
      • Roskilde, Danmark
        • 205.452.45016 Boehringer Ingelheim Investigational Site
      • Rødovre, Danmark
        • 205.452.45009 Boehringer Ingelheim Investigational Site
      • Rødovre, Danmark
        • 205.452.45010 Boehringer Ingelheim Investigational Site
      • Silkeborg, Danmark
        • 205.452.45004 Boehringer Ingelheim Investigational Site
      • Skive, Danmark
        • 205.452.45014 Boehringer Ingelheim Investigational Site
      • Sønderborg, Danmark
        • 205.452.45011 Boehringer Ingelheim Investigational Site
      • Viby, Danmark
        • 205.452.45015 Boehringer Ingelheim Investigational Site
      • Værløse, Danmark
        • 205.452.45007 Boehringer Ingelheim Investigational Site
  • Den Russiske Føderation
      • Arkhangelsk, Den Russiske Føderation
        • 205.452.07030 Boehringer Ingelheim Investigational Site
      • Barnaul, Den Russiske Føderation
        • 205.452.07049 Boehringer Ingelheim Investigational Site
      • Barnaul, Den Russiske Føderation
        • 205.452.07054 Boehringer Ingelheim Investigational Site
      • Chelyabinsk, Den Russiske Føderation
        • 205.452.07053 Boehringer Ingelheim Investigational Site
      • Ekaterinburg, Den Russiske Føderation
        • 205.452.07031 Boehringer Ingelheim Investigational Site
      • Gatchina (Leningradskaya oblast), Den Russiske Føderation
        • 205.452.07038 Boehringer Ingelheim Investigational Site
      • Irkutsk, Den Russiske Føderation
        • 205.452.07036 Boehringer Ingelheim Investigational Site
      • Ivanovo, Den Russiske Føderation
        • 205.452.07001 Boehringer Ingelheim Investigational Site
      • Kaliningrad, Den Russiske Føderation
        • 205.452.07023 Boehringer Ingelheim Investigational Site
      • Kazan, Den Russiske Føderation
        • 205.452.07003 Boehringer Ingelheim Investigational Site
      • Kazan, Den Russiske Føderation
        • 205.452.07005 Boehringer Ingelheim Investigational Site
      • Kazan, Den Russiske Føderation
        • 205.452.07007 Boehringer Ingelheim Investigational Site
      • Kemerovo, Den Russiske Føderation
        • 205.452.07048 Boehringer Ingelheim Investigational Site
      • Kemerovo, Den Russiske Føderation
        • 205.452.07060 Boehringer Ingelheim Investigational Site
      • Kirov, Den Russiske Føderation
        • 205.452.07059 Boehringer Ingelheim Investigational Site
      • Krasnodar, Den Russiske Føderation
        • 205.452.07009 Boehringer Ingelheim Investigational Site
      • Krasnodar, Den Russiske Føderation
        • 205.452.07010 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 205.452.07013 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 205.452.07020 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 205.452.07021 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 205.452.07026 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 205.452.07027 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 205.452.07028 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 205.452.07029 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 205.452.07043 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 205.452.07045 Boehringer Ingelheim Investigational Site
      • Murmansk, Den Russiske Føderation
        • 205.452.07004 Boehringer Ingelheim Investigational Site
      • Nizhniy Novgorod, Den Russiske Føderation
        • 205.452.07055 Boehringer Ingelheim Investigational Site
      • Nizhny Novgorod, Den Russiske Føderation
        • 205.452.07051 Boehringer Ingelheim Investigational Site
      • Novosibirsk, Den Russiske Føderation
        • 205.452.07037 Boehringer Ingelheim Investigational Site
      • Novosibirsk, Den Russiske Føderation
        • 205.452.07040 Boehringer Ingelheim Investigational Site
      • Novosibirsk, Den Russiske Føderation
        • 205.452.07042 Boehringer Ingelheim Investigational Site
      • Penza, Den Russiske Føderation
        • 205.452.07041 Boehringer Ingelheim Investigational Site
      • Pskov, Den Russiske Føderation
        • 205.452.07050 Boehringer Ingelheim Investigational Site
      • Rostov-na-Donu, Den Russiske Føderation
        • 205.452.07015 Boehringer Ingelheim Investigational Site
      • Rostov-on-Don, Den Russiske Føderation
        • 205.452.07016 Boehringer Ingelheim Investigational Site
      • Ryazan, Den Russiske Føderation
        • 205.452.07039 Boehringer Ingelheim Investigational Site
      • Samara, Den Russiske Føderation
        • 205.452.07034 Boehringer Ingelheim Investigational Site
      • Saratov, Den Russiske Føderation
        • 205.452.07047 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07002 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07006 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07011 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07014 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07017 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07018 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07022 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07024 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07025 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07033 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07046 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 205.452.07052 Boehringer Ingelheim Investigational Site
      • Tomsk, Den Russiske Føderation
        • 205.452.07032 Boehringer Ingelheim Investigational Site
      • Tomsk, Den Russiske Føderation
        • 205.452.07035 Boehringer Ingelheim Investigational Site
      • Tomsk, Den Russiske Føderation
        • 205.452.07057 Boehringer Ingelheim Investigational Site
      • Velikiy Novgorod, Den Russiske Føderation
        • 205.452.07019 Boehringer Ingelheim Investigational Site
      • Yaroslavl, Den Russiske Føderation
        • 205.452.07044 Boehringer Ingelheim Investigational Site
  • Det Forenede Kongerige
      • Atherstone, Det Forenede Kongerige
        • 205.452.44010 Boehringer Ingelheim Investigational Site
      • Burbage, Det Forenede Kongerige
        • 205.452.44008 Boehringer Ingelheim Investigational Site
      • Chertsey, Det Forenede Kongerige
        • 205.452.44004 Boehringer Ingelheim Investigational Site
      • Chesterfield, Det Forenede Kongerige
        • 205.452.44002 Boehringer Ingelheim Investigational Site
      • Coventry, Det Forenede Kongerige
        • 205.452.44003 Boehringer Ingelheim Investigational Site
      • Exeter, Det Forenede Kongerige
        • 205.452.44001 Boehringer Ingelheim Investigational Site
      • Fowey, Det Forenede Kongerige
        • 205.452.44007 Boehringer Ingelheim Investigational Site
      • Frome, Det Forenede Kongerige
        • 205.452.44005 Boehringer Ingelheim Investigational Site
      • Leamington Spa, Det Forenede Kongerige
        • 205.452.44011 Boehringer Ingelheim Investigational Site
      • St Just, Penzance, Det Forenede Kongerige
        • 205.452.44006 Boehringer Ingelheim Investigational Site
  • Filippinerne
      • Cavite City, Filippinerne
        • 205.452.63004 Boehringer Ingelheim Investigational Site
      • Davao City, Filippinerne
        • 205.452.63002 Boehringer Ingelheim Investigational Site
      • Iloilo City, Filippinerne
        • 205.452.63003 Boehringer Ingelheim Investigational Site
      • Iloilo City, Filippinerne
        • 205.452.63006 Boehringer Ingelheim Investigational Site
      • Manila, Filippinerne
        • 205.452.63001 Boehringer Ingelheim Investigational Site
      • Manila, Filippinerne
        • 205.452.63008 Boehringer Ingelheim Investigational Site
      • Quezon City, Filippinerne
        • 205.452.63005 Boehringer Ingelheim Investigational Site
      • Quezon City, Filippinerne
        • 205.452.63007 Boehringer Ingelheim Investigational Site
  • Finland
      • Helsinki, Finland
        • 205.452.35801 Boehringer Ingelheim Investigational Site
      • Lahti, Finland
        • 205.452.35804 Boehringer Ingelheim Investigational Site
      • Pori, Finland
        • 205.452.35808 Boehringer Ingelheim Investigational Site
      • Porvoo, Finland
        • 205.452.35805 Boehringer Ingelheim Investigational Site
      • Tammisaari, Finland
        • 205.452.35806 Boehringer Ingelheim Investigational Site
      • Tampere, Finland
        • 205.452.35802 Boehringer Ingelheim Investigational Site
      • Turku, Finland
        • 205.452.35803 Boehringer Ingelheim Investigational Site
  • Forenede Stater
    • Alabama
      • Athens, Alabama, Forenede Stater
        • 205.452.01107 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Forenede Stater
        • 205.452.01023 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Forenede Stater
        • 205.452.01035 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Forenede Stater
        • 205.452.01052 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Forenede Stater
        • 205.452.01219 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Forenede Stater
        • 205.452.01227 Boehringer Ingelheim Investigational Site
      • Birmingham, Alabama, Forenede Stater
        • 205.452.01280 Boehringer Ingelheim Investigational Site
      • Florence, Alabama, Forenede Stater
        • 205.452.01198 Boehringer Ingelheim Investigational Site
      • Mobile, Alabama, Forenede Stater
        • 205.452.01244 Boehringer Ingelheim Investigational Site
      • Montgomery, Alabama, Forenede Stater
        • 205.452.01041 Boehringer Ingelheim Investigational Site
    • Alaska
      • Anchorage, Alaska, Forenede Stater
        • 205.452.01070 Boehringer Ingelheim Investigational Site
    • Arizona
      • Chandler, Arizona, Forenede Stater
        • 205.452.01218 Boehringer Ingelheim Investigational Site
      • Mesa, Arizona, Forenede Stater
        • 205.452.01175 Boehringer Ingelheim Investigational Site
      • Mesa, Arizona, Forenede Stater
        • 205.452.01200 Boehringer Ingelheim Investigational Site
      • Mesa, Arizona, Forenede Stater
        • 205.452.01317 Boehringer Ingelheim Investigational Site
      • Pheonix, Arizona, Forenede Stater
        • 205.452.01350 Boehringer Ingelheim Investigational Site
      • Phoenix, Arizona, Forenede Stater
        • 205.452.01254 Boehringer Ingelheim Investigational Site
      • Phoenix, Arizona, Forenede Stater
        • 205.452.01283 Boehringer Ingelheim Investigational Site
      • Tempe, Arizona, Forenede Stater
        • 205.452.01315 Boehringer Ingelheim Investigational Site
      • Tucson, Arizona, Forenede Stater
        • 205.452.01158 Boehringer Ingelheim Investigational Site
      • Tucson, Arizona, Forenede Stater
        • 205.452.01161 Boehringer Ingelheim Investigational Site
    • California
      • Anaheim, California, Forenede Stater
        • 205.452.01302 Boehringer Ingelheim Investigational Site
      • Encinitas, California, Forenede Stater
        • 205.452.01038 Boehringer Ingelheim Investigational Site
      • Fountain Valley, California, Forenede Stater
        • 205.452.01313 Boehringer Ingelheim Investigational Site
      • Fountain Valley, California, Forenede Stater
        • 205.452.01375 Boehringer Ingelheim Investigational Site
      • Fullerton, California, Forenede Stater
        • 205.452.01074 Boehringer Ingelheim Investigational Site
      • Lancaster, California, Forenede Stater
        • 205.452.01345 Boehringer Ingelheim Investigational Site
      • Lincoln, California, Forenede Stater
        • 205.452.01171 Boehringer Ingelheim Investigational Site
      • Lomita, California, Forenede Stater
        • 205.452.01339 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 205.452.01298 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 205.452.01356 Boehringer Ingelheim Investigational Site
      • Orange, California, Forenede Stater
        • 205.452.01148 Boehringer Ingelheim Investigational Site
      • Palm Springs, California, Forenede Stater
        • 205.452.01111 Boehringer Ingelheim Investigational Site
      • Paramount, California, Forenede Stater
        • 205.452.01147 Boehringer Ingelheim Investigational Site
      • Poway, California, Forenede Stater
        • 205.452.01071 Boehringer Ingelheim Investigational Site
      • Rancho Cucamonga, California, Forenede Stater
        • 205.452.01089 Boehringer Ingelheim Investigational Site
      • Redlands, California, Forenede Stater
        • 205.452.01097 Boehringer Ingelheim Investigational Site
      • San Diego, California, Forenede Stater
        • 205.452.01078 Boehringer Ingelheim Investigational Site
      • San Diego, California, Forenede Stater
        • 205.452.01176 Boehringer Ingelheim Investigational Site
      • San Diego, California, Forenede Stater
        • 205.452.01346 Boehringer Ingelheim Investigational Site
      • San Jose, California, Forenede Stater
        • 205.452.01306 Boehringer Ingelheim Investigational Site
      • Santa Barbara, California, Forenede Stater
        • 205.452.01297 Boehringer Ingelheim Investigational Site
      • Tustin, California, Forenede Stater
        • 205.452.01362 Boehringer Ingelheim Investigational Site
      • Victorville, California, Forenede Stater
        • 205.452.01225 Boehringer Ingelheim Investigational Site
      • Walnut Creek, California, Forenede Stater
        • 205.452.01224 Boehringer Ingelheim Investigational Site
      • Wildomar, California, Forenede Stater
        • 205.452.01236 Boehringer Ingelheim Investigational Site
    • Colorado
      • Colorado Springs, Colorado, Forenede Stater
        • 205.452.01049 Boehringer Ingelheim Investigational Site
      • Colorado Springs, Colorado, Forenede Stater
        • 205.452.01245 Boehringer Ingelheim Investigational Site
      • Denver, Colorado, Forenede Stater
        • 205.452.01351 Boehringer Ingelheim Investigational Site
      • Fort Collins, Colorado, Forenede Stater
        • 205.452.01018 Boehringer Ingelheim Investigational Site
      • Wheat Ridge, Colorado, Forenede Stater
        • 205.452.01005 Boehringer Ingelheim Investigational Site
      • Wheat Ridge, Colorado, Forenede Stater
        • 205.452.01024 Boehringer Ingelheim Investigational Site
    • Connecticut
      • Danbury, Connecticut, Forenede Stater
        • 205.452.01199 Boehringer Ingelheim Investigational Site
      • Hartford, Connecticut, Forenede Stater
        • 205.452.01054 Boehringer Ingelheim Investigational Site
      • Norwalk, Connecticut, Forenede Stater
        • 205.452.01072 Boehringer Ingelheim Investigational Site
      • Stamford, Connecticut, Forenede Stater
        • 205.452.01040 Boehringer Ingelheim Investigational Site
      • Waterbury, Connecticut, Forenede Stater
        • 205.452.01109 Boehringer Ingelheim Investigational Site
    • Delaware
      • Newark, Delaware, Forenede Stater
        • 205.452.01308 Boehringer Ingelheim Investigational Site
    • Florida
      • Clearwater, Florida, Forenede Stater
        • 205.452.01011 Boehringer Ingelheim Investigational Site
      • Hialeah, Florida, Forenede Stater
        • 205.452.01209 Boehringer Ingelheim Investigational Site
      • Homestead, Florida, Forenede Stater
        • 205.452.01360 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 205.452.01241 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 205.452.01337 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 205.452.01343 Boehringer Ingelheim Investigational Site
      • Jupiter, Florida, Forenede Stater
        • 205.452.01184 Boehringer Ingelheim Investigational Site
      • Miami, Florida, Forenede Stater
        • 205.452.01138 Boehringer Ingelheim Investigational Site
      • Miami, Florida, Forenede Stater
        • 205.452.01246 Boehringer Ingelheim Investigational Site
      • Miami, Florida, Forenede Stater
        • 205.452.01321 Boehringer Ingelheim Investigational Site
      • New Port Richey, Florida, Forenede Stater
        • 205.452.01290 Boehringer Ingelheim Investigational Site
      • Ocala, Florida, Forenede Stater
        • 205.452.01203 Boehringer Ingelheim Investigational Site
      • Orlando, Florida, Forenede Stater
        • 205.452.01174 Boehringer Ingelheim Investigational Site
      • Ormond Beach, Florida, Forenede Stater
        • 205.452.01135 Boehringer Ingelheim Investigational Site
      • Oviedo, Florida, Forenede Stater
        • 205.452.01173 Boehringer Ingelheim Investigational Site
      • Panama City, Florida, Forenede Stater
        • 205.452.01195 Boehringer Ingelheim Investigational Site
      • Panama City, Florida, Forenede Stater
        • 205.452.01197 Boehringer Ingelheim Investigational Site
      • Pembroke Pines, Florida, Forenede Stater
        • 205.452.01239 Boehringer Ingelheim Investigational Site
      • Pembroke Pines, Florida, Forenede Stater
        • 205.452.01247 Boehringer Ingelheim Investigational Site
      • Pembroke Pines, Florida, Forenede Stater
        • 205.452.01286 Boehringer Ingelheim Investigational Site
      • Pensacola, Florida, Forenede Stater
        • 205.452.01240 Boehringer Ingelheim Investigational Site
      • Ponte Vedra, Florida, Forenede Stater
        • 205.452.01260 Boehringer Ingelheim Investigational Site
      • Rockledge, Florida, Forenede Stater
        • 205.452.01092 Boehringer Ingelheim Investigational Site
      • Sarasota, Florida, Forenede Stater
        • 205.452.01251 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Florida, Forenede Stater
        • 205.452.01133 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Florida, Forenede Stater
        • 205.452.01136 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Florida, Forenede Stater
        • 205.452.01207 Boehringer Ingelheim Investigational Site
      • Tamarac, Florida, Forenede Stater
        • 205.452.01134 Boehringer Ingelheim Investigational Site
      • Tamarac, Florida, Forenede Stater
        • 205.452.01231 Boehringer Ingelheim Investigational Site
      • Tampa, Florida, Forenede Stater
        • 205.452.01025 Boehringer Ingelheim Investigational Site
      • Tampa, Florida, Forenede Stater
        • 205.452.01250 Boehringer Ingelheim Investigational Site
      • Winter Park, Florida, Forenede Stater
        • 205.452.01060 Boehringer Ingelheim Investigational Site
    • Georgia
      • Atlanta, Georgia, Forenede Stater
        • 205.452.01130 Boehringer Ingelheim Investigational Site
      • Austell, Georgia, Forenede Stater
        • 205.452.01047 Boehringer Ingelheim Investigational Site
      • Columbus, Georgia, Forenede Stater
        • 205.452.01255 Boehringer Ingelheim Investigational Site
      • Conyers, Georgia, Forenede Stater
        • 205.452.01012 Boehringer Ingelheim Investigational Site
      • Gainesville, Georgia, Forenede Stater
        • 205.452.01299 Boehringer Ingelheim Investigational Site
      • Lawrenceville, Georgia, Forenede Stater
        • 205.452.01288 Boehringer Ingelheim Investigational Site
      • Snellville, Georgia, Forenede Stater
        • 205.452.01090 Boehringer Ingelheim Investigational Site
    • Hawaii
      • Honolulu, Hawaii, Forenede Stater
        • 205.452.01100 Boehringer Ingelheim Investigational Site
    • Idaho
      • Boise, Idaho, Forenede Stater
        • 205.452.01165 Boehringer Ingelheim Investigational Site
      • Coeur d'Alene, Idaho, Forenede Stater
        • 205.452.01059 Boehringer Ingelheim Investigational Site
      • Eagle, Idaho, Forenede Stater
        • 205.452.01062 Boehringer Ingelheim Investigational Site
      • Hayden Lake, Idaho, Forenede Stater
        • 205.452.01166 Boehringer Ingelheim Investigational Site
      • Meridian, Idaho, Forenede Stater
        • 205.452.01275 Boehringer Ingelheim Investigational Site
    • Illinois
      • Arlington Heights, Illinois, Forenede Stater
        • 205.452.01330 Boehringer Ingelheim Investigational Site
      • Belleville, Illinois, Forenede Stater
        • 205.452.01248 Boehringer Ingelheim Investigational Site
      • Chicago, Illinois, Forenede Stater
        • 205.452.01278 Boehringer Ingelheim Investigational Site
      • Downer Grove, Illinois, Forenede Stater
        • 205.452.01371 Boehringer Ingelheim Investigational Site
      • Lombard, Illinois, Forenede Stater
        • 205.452.01235 Boehringer Ingelheim Investigational Site
      • O'Fallon, Illinois, Forenede Stater
        • 205.452.01180 Boehringer Ingelheim Investigational Site
      • Oak Park, Illinois, Forenede Stater
        • 205.452.01268 Boehringer Ingelheim Investigational Site
      • Quincy, Illinois, Forenede Stater
        • 205.452.01359 Boehringer Ingelheim Investigational Site
    • Indiana
      • Brownsburg, Indiana, Forenede Stater
        • 205.452.01347 Boehringer Ingelheim Investigational Site
      • Evansville, Indiana, Forenede Stater
        • 205.452.01153 Boehringer Ingelheim Investigational Site
      • Fishers, Indiana, Forenede Stater
        • 205.452.01301 Boehringer Ingelheim Investigational Site
      • Franklin, Indiana, Forenede Stater
        • 205.452.01141 Boehringer Ingelheim Investigational Site
      • Lafayette, Indiana, Forenede Stater
        • 205.452.01137 Boehringer Ingelheim Investigational Site
      • Muncie, Indiana, Forenede Stater
        • 205.452.01263 Boehringer Ingelheim Investigational Site
    • Iowa
      • Council Bluffs, Iowa, Forenede Stater
        • 205.452.01284 Boehringer Ingelheim Investigational Site
      • Dubuque, Iowa, Forenede Stater
        • 205.452.01021 Boehringer Ingelheim Investigational Site
    • Kansas
      • Lansing, Kansas, Forenede Stater
        • 205.452.01305 Boehringer Ingelheim Investigational Site
      • Olathe, Kansas, Forenede Stater
        • 205.452.01304 Boehringer Ingelheim Investigational Site
      • Overland Park, Kansas, Forenede Stater
        • 205.452.01125 Boehringer Ingelheim Investigational Site
      • Topeka, Kansas, Forenede Stater
        • 205.452.01068 Boehringer Ingelheim Investigational Site
    • Kentucky
      • Bowling Green, Kentucky, Forenede Stater
        • 205.452.01063 Boehringer Ingelheim Investigational Site
      • Fort Mitchell, Kentucky, Forenede Stater
        • 205.452.01206 Boehringer Ingelheim Investigational Site
      • Louisville, Kentucky, Forenede Stater
        • 205.452.01289 Boehringer Ingelheim Investigational Site
      • Paducah, Kentucky, Forenede Stater
        • 205.452.01152 Boehringer Ingelheim Investigational Site
    • Louisiana
      • Lafayette, Louisiana, Forenede Stater
        • 205.452.01015 Boehringer Ingelheim Investigational Site
      • Shreveport, Louisiana, Forenede Stater
        • 205.452.01091 Boehringer Ingelheim Investigational Site
      • Shreveport, Louisiana, Forenede Stater
        • 205.452.01329 Boehringer Ingelheim Investigational Site
    • Maine
      • Auburn, Maine, Forenede Stater
        • 205.452.01364 Boehringer Ingelheim Investigational Site
      • Bangor, Maine, Forenede Stater
        • 205.452.01169 Boehringer Ingelheim Investigational Site
      • Biddeford, Maine, Forenede Stater
        • 205.452.01022 Boehringer Ingelheim Investigational Site
    • Maryland
      • Baltimore, Maryland, Forenede Stater
        • 205.452.01053 Boehringer Ingelheim Investigational Site
      • Elkridge, Maryland, Forenede Stater
        • 205.452.01190 Boehringer Ingelheim Investigational Site
      • Hollywood, Maryland, Forenede Stater
        • 205.452.01336 Boehringer Ingelheim Investigational Site
      • Towson, Maryland, Forenede Stater
        • 205.452.01238 Boehringer Ingelheim Investigational Site
      • Towson, Maryland, Forenede Stater
        • 205.452.01243 Boehringer Ingelheim Investigational Site
    • Massachusetts
      • Fall River, Massachusetts, Forenede Stater
        • 205.452.01366 Boehringer Ingelheim Investigational Site
      • Haverhill, Massachusetts, Forenede Stater
        • 205.452.01269 Boehringer Ingelheim Investigational Site
      • New Bedford, Massachusetts, Forenede Stater
        • 205.452.01208 Boehringer Ingelheim Investigational Site
      • Worcester, Massachusetts, Forenede Stater
        • 205.452.01170 Boehringer Ingelheim Investigational Site
    • Michigan
      • Ann Arbor, Michigan, Forenede Stater
        • 205.452.01270 Boehringer Ingelheim Investigational Site
      • Benzonia, Michigan, Forenede Stater
        • 205.452.01349 Boehringer Ingelheim Investigational Site
      • Chelsea, Michigan, Forenede Stater
        • 205.452.01365 Boehringer Ingelheim Investigational Site
      • Chesterfield, Michigan, Forenede Stater
        • 205.452.01149 Boehringer Ingelheim Investigational Site
      • Detroit, Michigan, Forenede Stater
        • 205.452.01146 Boehringer Ingelheim Investigational Site
      • Interlochen, Michigan, Forenede Stater
        • 205.452.01139 Boehringer Ingelheim Investigational Site
      • Kalamazoo, Michigan, Forenede Stater
        • 205.452.01080 Boehringer Ingelheim Investigational Site
      • Stevensville, Michigan, Forenede Stater
        • 205.452.01310 Boehringer Ingelheim Investigational Site
      • Traverse City, Michigan, Forenede Stater
        • 205.452.01122 Boehringer Ingelheim Investigational Site
      • Troy, Michigan, Forenede Stater
        • 205.452.01081 Boehringer Ingelheim Investigational Site
      • Troy, Michigan, Forenede Stater
        • 205.452.01221 Boehringer Ingelheim Investigational Site
    • Minnesota
      • Chaska, Minnesota, Forenede Stater
        • 205.452.01205 Boehringer Ingelheim Investigational Site
      • Edina, Minnesota, Forenede Stater
        • 205.452.01211 Boehringer Ingelheim Investigational Site
      • Fridley, Minnesota, Forenede Stater
        • 205.452.01104 Boehringer Ingelheim Investigational Site
      • Minneapolis, Minnesota, Forenede Stater
        • 205.452.01113 Boehringer Ingelheim Investigational Site
      • Rochester, Minnesota, Forenede Stater
        • 205.452.01042 Boehringer Ingelheim Investigational Site
    • Mississippi
      • Olive Branch, Mississippi, Forenede Stater
        • 205.452.01019 Boehringer Ingelheim Investigational Site
    • Missouri
      • Chesterfield, Missouri, Forenede Stater
        • 205.452.01014 Boehringer Ingelheim Investigational Site
      • St. Charles, Missouri, Forenede Stater
        • 205.452.01129 Boehringer Ingelheim Investigational Site
      • St. Louis, Missouri, Forenede Stater
        • 205.452.01110 Boehringer Ingelheim Investigational Site
      • West Plains, Missouri, Forenede Stater
        • 205.452.01179 Boehringer Ingelheim Investigational Site
    • Montana
      • Billings, Montana, Forenede Stater
        • 205.452.01226 Boehringer Ingelheim Investigational Site
      • Butte, Montana, Forenede Stater
        • 205.452.01076 Boehringer Ingelheim Investigational Site
      • Missoula, Montana, Forenede Stater
        • 205.452.01196 Boehringer Ingelheim Investigational Site
    • Nebraska
      • Bellevue, Nebraska, Forenede Stater
        • 205.452.01150 Boehringer Ingelheim Investigational Site
      • Fremont, Nebraska, Forenede Stater
        • 205.452.01187 Boehringer Ingelheim Investigational Site
      • Omaha, Nebraska, Forenede Stater
        • 205.452.01155 Boehringer Ingelheim Investigational Site
    • Nevada
      • Henderson, Nevada, Forenede Stater
        • 205.452.01073 Boehringer Ingelheim Investigational Site
      • Las Vegas, Nevada, Forenede Stater
        • 205.452.01031 Boehringer Ingelheim Investigational Site
      • Las Vegas, Nevada, Forenede Stater
        • 205.452.01261 Boehringer Ingelheim Investigational Site
    • New Hampshire
      • Lebanon, New Hampshire, Forenede Stater
        • 205.452.01026 Boehringer Ingelheim Investigational Site
      • Newington, New Hampshire, Forenede Stater
        • 205.452.01369 Boehringer Ingelheim Investigational Site
    • New Jersey
      • Ocean, New Jersey, Forenede Stater
        • 205.452.01296 Boehringer Ingelheim Investigational Site
      • Toms River, New Jersey, Forenede Stater
        • 205.452.01046 Boehringer Ingelheim Investigational Site
    • New Mexico
      • Albuquerque, New Mexico, Forenede Stater
        • 205.452.01061 Boehringer Ingelheim Investigational Site
      • Albuquerque, New Mexico, Forenede Stater
        • 205.452.01167 Boehringer Ingelheim Investigational Site
    • New York
      • Bayside, New York, Forenede Stater
        • 205.452.01159 Boehringer Ingelheim Investigational Site
      • Bronxville, New York, Forenede Stater
        • 205.452.01163 Boehringer Ingelheim Investigational Site
      • Cooperstown, New York, Forenede Stater
        • 205.452.01194 Boehringer Ingelheim Investigational Site
      • Elmira, New York, Forenede Stater
        • 205.452.01131 Boehringer Ingelheim Investigational Site
      • Endwell, New York, Forenede Stater
        • 205.452.01142 Boehringer Ingelheim Investigational Site
      • Glens Falls, New York, Forenede Stater
        • 205.452.01192 Boehringer Ingelheim Investigational Site
      • Great Neck, New York, Forenede Stater
        • 205.452.01279 Boehringer Ingelheim Investigational Site
      • Honeoye Falls, New York, Forenede Stater
        • 205.452.01328 Boehringer Ingelheim Investigational Site
      • New Windsor, New York, Forenede Stater
        • 205.452.01118 Boehringer Ingelheim Investigational Site
      • New York, New York, Forenede Stater
        • 205.452.01127 Boehringer Ingelheim Investigational Site
      • Rochester, New York, Forenede Stater
        • 205.452.01058 Boehringer Ingelheim Investigational Site
      • Syracuse, New York, Forenede Stater
        • 205.452.01085 Boehringer Ingelheim Investigational Site
      • Syracuse, New York, Forenede Stater
        • 205.452.01293 Boehringer Ingelheim Investigational Site
      • Vestal, New York, Forenede Stater
        • 205.452.01151 Boehringer Ingelheim Investigational Site
      • Westfield, New York, Forenede Stater
        • 205.452.01188 Boehringer Ingelheim Investigational Site
    • North Carolina
      • Asheville, North Carolina, Forenede Stater
        • 205.452.01271 Boehringer Ingelheim Investigational Site
      • Burlington, North Carolina, Forenede Stater
        • 205.452.01101 Boehringer Ingelheim Investigational Site
      • Calabash, North Carolina, Forenede Stater
        • 205.452.01264 Boehringer Ingelheim Investigational Site
      • Charlotte, North Carolina, Forenede Stater
        • 205.452.01168 Boehringer Ingelheim Investigational Site
      • Elizabeth City, North Carolina, Forenede Stater
        • 205.452.01108 Boehringer Ingelheim Investigational Site
      • Greensboro, North Carolina, Forenede Stater
        • 205.452.01033 Boehringer Ingelheim Investigational Site
      • Greensboro, North Carolina, Forenede Stater
        • 205.452.01172 Boehringer Ingelheim Investigational Site
      • Hickory, North Carolina, Forenede Stater
        • 205.452.01098 Boehringer Ingelheim Investigational Site
      • Hickory, North Carolina, Forenede Stater
        • 205.452.01115 Boehringer Ingelheim Investigational Site
      • Raleigh, North Carolina, Forenede Stater
        • 205.452.01128 Boehringer Ingelheim Investigational Site
      • Rocky Mount, North Carolina, Forenede Stater
        • 205.452.01352 Boehringer Ingelheim Investigational Site
      • Salisbury, North Carolina, Forenede Stater
        • 205.452.01348 Boehringer Ingelheim Investigational Site
      • Statesville, North Carolina, Forenede Stater
        • 205.452.01032 Boehringer Ingelheim Investigational Site
      • Tabor City, North Carolina, Forenede Stater
        • 205.452.01276 Boehringer Ingelheim Investigational Site
      • Wilmington, North Carolina, Forenede Stater
        • 205.452.01157 Boehringer Ingelheim Investigational Site
      • Winston Salem, North Carolina, Forenede Stater
        • 205.452.01363 Boehringer Ingelheim Investigational Site
    • Ohio
      • Canal Fulton, Ohio, Forenede Stater
        • 205.452.01193 Boehringer Ingelheim Investigational Site
      • Centerville, Ohio, Forenede Stater
        • 205.452.01374 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Forenede Stater
        • 205.452.01006 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Forenede Stater
        • 205.452.01373 Boehringer Ingelheim Investigational Site
      • Cleveland, Ohio, Forenede Stater
        • 205.452.01314 Boehringer Ingelheim Investigational Site
      • Columbus, Ohio, Forenede Stater
        • 205.452.01210 Boehringer Ingelheim Investigational Site
      • Columbus, Ohio, Forenede Stater
        • 205.452.01232 Boehringer Ingelheim Investigational Site
      • Dayton, Ohio, Forenede Stater
        • 205.452.01309 Boehringer Ingelheim Investigational Site
      • Delaware, Ohio, Forenede Stater
        • 205.452.01140 Boehringer Ingelheim Investigational Site
      • Sylvania, Ohio, Forenede Stater
        • 205.452.01084 Boehringer Ingelheim Investigational Site
      • Toledo, Ohio, Forenede Stater
        • 205.452.01287 Boehringer Ingelheim Investigational Site
    • Oklahoma
      • Oklahoma City, Oklahoma, Forenede Stater
        • 205.452.01010 Boehringer Ingelheim Investigational Site
      • Oklahoma City, Oklahoma, Forenede Stater
        • 205.452.01094 Boehringer Ingelheim Investigational Site
      • Tulsa, Oklahoma, Forenede Stater
        • 205.452.01029 Boehringer Ingelheim Investigational Site
      • Tulsa, Oklahoma, Forenede Stater
        • 205.452.01043 Boehringer Ingelheim Investigational Site
    • Oregon
      • Ashland, Oregon, Forenede Stater
        • 205.452.01266 Boehringer Ingelheim Investigational Site
      • Bend, Oregon, Forenede Stater
        • 205.452.01083 Boehringer Ingelheim Investigational Site
      • Corvallis, Oregon, Forenede Stater
        • 205.452.01189 Boehringer Ingelheim Investigational Site
      • Springfield, Oregon, Forenede Stater
        • 205.452.01341 Boehringer Ingelheim Investigational Site
    • Pennsylvania
      • Altoona, Pennsylvania, Forenede Stater
        • 205.452.01002 Boehringer Ingelheim Investigational Site
      • Beaver, Pennsylvania, Forenede Stater
        • 205.452.01354 Boehringer Ingelheim Investigational Site
      • Carnegie, Pennsylvania, Forenede Stater
        • 205.452.01143 Boehringer Ingelheim Investigational Site
      • Downingtown, Pennsylvania, Forenede Stater
        • 205.452.01320 Boehringer Ingelheim Investigational Site
      • Erie, Pennsylvania, Forenede Stater
        • 205.452.01323 Boehringer Ingelheim Investigational Site
      • Jefferson Hills, Pennsylvania, Forenede Stater
        • 205.452.01257 Boehringer Ingelheim Investigational Site
      • Langhorne, Pennsylvania, Forenede Stater
        • 205.452.01332 Boehringer Ingelheim Investigational Site
      • Norristown, Pennsylvania, Forenede Stater
        • 205.452.01075 Boehringer Ingelheim Investigational Site
      • Philadelphia, Pennsylvania, Forenede Stater
        • 205.452.01087 Boehringer Ingelheim Investigational Site
      • Philadelphia, Pennsylvania, Forenede Stater
        • 205.452.01144 Boehringer Ingelheim Investigational Site
      • Pittsburgh, Pennsylvania, Forenede Stater
        • 205.452.01003 Boehringer Ingelheim Investigational Site
      • Pittsburgh, Pennsylvania, Forenede Stater
        • 205.452.01361 Boehringer Ingelheim Investigational Site
      • Pleasant Hills, Pennsylvania, Forenede Stater
        • 205.452.01036 Boehringer Ingelheim Investigational Site
      • Uniontown, Pennsylvania, Forenede Stater
        • 205.452.01106 Boehringer Ingelheim Investigational Site
      • Uniontown, Pennsylvania, Forenede Stater
        • 205.452.01156 Boehringer Ingelheim Investigational Site
      • Warminster, Pennsylvania, Forenede Stater
        • 205.452.01204 Boehringer Ingelheim Investigational Site
      • Wyomissing, Pennsylvania, Forenede Stater
        • 205.452.01338 Boehringer Ingelheim Investigational Site
    • Rhode Island
      • Cranston, Rhode Island, Forenede Stater
        • 205.452.01267 Boehringer Ingelheim Investigational Site
      • Johnston, Rhode Island, Forenede Stater
        • 205.452.01214 Boehringer Ingelheim Investigational Site
    • South Carolina
      • Anderson, South Carolina, Forenede Stater
        • 205.452.01340 Boehringer Ingelheim Investigational Site
      • Charleston, South Carolina, Forenede Stater
        • 205.452.01066 Boehringer Ingelheim Investigational Site
      • Columbia, South Carolina, Forenede Stater
        • 205.452.01217 Boehringer Ingelheim Investigational Site
      • Easley, South Carolina, Forenede Stater
        • 205.452.01303 Boehringer Ingelheim Investigational Site
      • Florence, South Carolina, Forenede Stater
        • 205.452.01259 Boehringer Ingelheim Investigational Site
      • Gaffney, South Carolina, Forenede Stater
        • 205.452.01013 Boehringer Ingelheim Investigational Site
      • Greenville, South Carolina, Forenede Stater
        • 205.452.01077 Boehringer Ingelheim Investigational Site
      • Greer, South Carolina, Forenede Stater
        • 205.452.01093 Boehringer Ingelheim Investigational Site
      • Hodges, South Carolina, Forenede Stater
        • 205.452.01295 Boehringer Ingelheim Investigational Site
      • Myrtle Beach, South Carolina, Forenede Stater
        • 205.452.01335 Boehringer Ingelheim Investigational Site
      • Rock Hill, South Carolina, Forenede Stater
        • 205.452.01056 Boehringer Ingelheim Investigational Site
      • Spartanburg, South Carolina, Forenede Stater
        • 205.452.01294 Boehringer Ingelheim Investigational Site
    • South Dakota
      • Rapid City, South Dakota, Forenede Stater
        • 205.452.01004 Boehringer Ingelheim Investigational Site
    • Tennessee
      • Brentwood, Tennessee, Forenede Stater
        • 205.452.01126 Boehringer Ingelheim Investigational Site
      • Chattanooga, Tennessee, Forenede Stater
        • 205.452.01220 Boehringer Ingelheim Investigational Site
      • Chattanooga, Tennessee, Forenede Stater
        • 205.452.01324 Boehringer Ingelheim Investigational Site
      • Kingsport, Tennessee, Forenede Stater
        • 205.452.01342 Boehringer Ingelheim Investigational Site
    • Texas
      • Arlington, Texas, Forenede Stater
        • 205.452.01096 Boehringer Ingelheim Investigational Site
      • Corsicana, Texas, Forenede Stater
        • 205.452.01050 Boehringer Ingelheim Investigational Site
      • Dallas, Texas, Forenede Stater
        • 205.452.01233 Boehringer Ingelheim Investigational Site
      • Dallas, Texas, Forenede Stater
        • 205.452.01334 Boehringer Ingelheim Investigational Site
      • Fort Worth, Texas, Forenede Stater
        • 205.452.01057 Boehringer Ingelheim Investigational Site
      • Fort Worth, Texas, Forenede Stater
        • 205.452.01181 Boehringer Ingelheim Investigational Site
      • Fort Worth, Texas, Forenede Stater
        • 205.452.01272 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Forenede Stater
        • 205.452.01082 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Forenede Stater
        • 205.452.01105 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Forenede Stater
        • 205.452.01178 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Forenede Stater
        • 205.452.01212 Boehringer Ingelheim Investigational Site
      • Longview, Texas, Forenede Stater
        • 205.452.01274 Boehringer Ingelheim Investigational Site
      • McKinney, Texas, Forenede Stater
        • 205.452.01116 Boehringer Ingelheim Investigational Site
      • Richardson, Texas, Forenede Stater
        • 205.452.01262 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Forenede Stater
        • 205.452.01055 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Forenede Stater
        • 205.452.01182 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Forenede Stater
        • 205.452.01186 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Forenede Stater
        • 205.452.01353 Boehringer Ingelheim Investigational Site
      • Sugar Land, Texas, Forenede Stater
        • 205.452.01215 Boehringer Ingelheim Investigational Site
    • Utah
      • Midvale, Utah, Forenede Stater
        • 205.452.01223 Boehringer Ingelheim Investigational Site
      • Salt Lake City, Utah, Forenede Stater
        • 205.452.01001 Boehringer Ingelheim Investigational Site
    • Virginia
      • Abingdon, Virginia, Forenede Stater
        • 205.452.01079 Boehringer Ingelheim Investigational Site
      • Alexandria, Virginia, Forenede Stater
        • 205.452.01234 Boehringer Ingelheim Investigational Site
      • Danville, Virginia, Forenede Stater
        • 205.452.01065 Boehringer Ingelheim Investigational Site
      • Danville, Virginia, Forenede Stater
        • 205.452.01285 Boehringer Ingelheim Investigational Site
      • Ettrick, Virginia, Forenede Stater
        • 205.452.01045 Boehringer Ingelheim Investigational Site
      • Lynchburg, Virginia, Forenede Stater
        • 205.452.01030 Boehringer Ingelheim Investigational Site
      • Richmond, Virginia, Forenede Stater
        • 205.452.01016 Boehringer Ingelheim Investigational Site
      • Richmond, Virginia, Forenede Stater
        • 205.452.01039 Boehringer Ingelheim Investigational Site
      • Richmond, Virginia, Forenede Stater
        • 205.452.01044 Boehringer Ingelheim Investigational Site
      • Richmond, Virginia, Forenede Stater
        • 205.452.01300 Boehringer Ingelheim Investigational Site
    • Washington
      • Selah, Washington, Forenede Stater
        • 205.452.01099 Boehringer Ingelheim Investigational Site
      • Spokane, Washington, Forenede Stater
        • 205.452.01008 Boehringer Ingelheim Investigational Site
      • Spokane, Washington, Forenede Stater
        • 205.452.01069 Boehringer Ingelheim Investigational Site
      • Spokane, Washington, Forenede Stater
        • 205.452.01145 Boehringer Ingelheim Investigational Site
      • Tacoma, Washington, Forenede Stater
        • 205.452.01185 Boehringer Ingelheim Investigational Site
      • Wenatchee, Washington, Forenede Stater
        • 205.452.01007 Boehringer Ingelheim Investigational Site
    • Wisconsin
      • Oregon, Wisconsin, Forenede Stater
        • 205.452.01201 Boehringer Ingelheim Investigational Site
      • West Allis, Wisconsin, Forenede Stater
        • 205.452.01344 Boehringer Ingelheim Investigational Site
  • Frankrig
      • Albens, Frankrig
        • 205.452.33087 Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 205.452.33028 Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 205.452.33055 Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 205.452.33142 Boehringer Ingelheim Investigational Site
      • Angers, Frankrig
        • 205.452.33159 Boehringer Ingelheim Investigational Site
      • Anzin, Frankrig
        • 205.452.33030 Boehringer Ingelheim Investigational Site
      • Arras, Frankrig
        • 205.452.33158 Boehringer Ingelheim Investigational Site
      • Avrillé, Frankrig
        • 205.452.33084 Boehringer Ingelheim Investigational Site
      • Becon les Granits, Frankrig
        • 205.452.33128 Boehringer Ingelheim Investigational Site
      • Bersée, Frankrig
        • 205.452.33029 Boehringer Ingelheim Investigational Site
      • Beziers, Frankrig
        • 205.452.33018 Boehringer Ingelheim Investigational Site
      • Bischheim, Frankrig
        • 205.452.33053 Boehringer Ingelheim Investigational Site
      • Blois, Frankrig
        • 205.452.33024 Boehringer Ingelheim Investigational Site
      • Bort les Orgues, Frankrig
        • 205.452.33043 Boehringer Ingelheim Investigational Site
      • Bourg des cptes, Frankrig
        • 205.452.33091 Boehringer Ingelheim Investigational Site
      • Briollay, Frankrig
        • 205.452.33123 Boehringer Ingelheim Investigational Site
      • Broglie, Frankrig
        • 205.452.33063 Boehringer Ingelheim Investigational Site
      • Bruay La Buissiere, Frankrig
        • 205.452.33074 Boehringer Ingelheim Investigational Site
      • Cannes, Frankrig
        • 205.452.33118 Boehringer Ingelheim Investigational Site
      • Cannes Cedex, Frankrig
        • 205.452.33010 Boehringer Ingelheim Investigational Site
      • Chamalières, Frankrig
        • 205.452.33009 Boehringer Ingelheim Investigational Site
      • Chambery, Frankrig
        • 205.452.33073 Boehringer Ingelheim Investigational Site
      • Chateau Renault, Frankrig
        • 205.452.33059 Boehringer Ingelheim Investigational Site
      • Colombey les Belles, Frankrig
        • 205.452.33089 Boehringer Ingelheim Investigational Site
      • Cournonterral, Frankrig
        • 205.452.33099 Boehringer Ingelheim Investigational Site
      • Cournonterral, Frankrig
        • 205.452.33127 Boehringer Ingelheim Investigational Site
      • Croix, Frankrig
        • 205.452.33162 Boehringer Ingelheim Investigational Site
      • Dinard, Frankrig
        • 205.452.33105 Boehringer Ingelheim Investigational Site
      • Donges, Frankrig
        • 205.452.33110 Boehringer Ingelheim Investigational Site
      • Gambsheim, Frankrig
        • 205.452.33094 Boehringer Ingelheim Investigational Site
      • Grenoble, Frankrig
        • 205.452.33046 Boehringer Ingelheim Investigational Site
      • Hautmont, Frankrig
        • 205.452.33096 Boehringer Ingelheim Investigational Site
      • Hinx, Frankrig
        • 205.452.33090 Boehringer Ingelheim Investigational Site
      • Jarny, Frankrig
        • 205.452.33145 Boehringer Ingelheim Investigational Site
      • La Bouëxière, Frankrig
        • 205.452.33154 Boehringer Ingelheim Investigational Site
      • La Chapelle sur Erdre, Frankrig
        • 205.452.33065 Boehringer Ingelheim Investigational Site
      • La Montagne, Frankrig
        • 205.452.33102 Boehringer Ingelheim Investigational Site
      • La Riche, Frankrig
        • 205.452.33100 Boehringer Ingelheim Investigational Site
      • Lambersart, Frankrig
        • 205.452.33058 Boehringer Ingelheim Investigational Site
      • Lambersart, Frankrig
        • 205.452.33098 Boehringer Ingelheim Investigational Site
      • Levallois Perret, Frankrig
        • 205.452.33103 Boehringer Ingelheim Investigational Site
      • Louvigne De bais, Frankrig
        • 205.452.33164 Boehringer Ingelheim Investigational Site
      • Luynes, Frankrig
        • 205.452.33111 Boehringer Ingelheim Investigational Site
      • Marcq en Baroeul, Frankrig
        • 205.452.33136 Boehringer Ingelheim Investigational Site
      • Mondelange, Frankrig
        • 205.452.33115 Boehringer Ingelheim Investigational Site
      • Mont de Marsan, Frankrig
        • 205.452.33088 Boehringer Ingelheim Investigational Site
      • Mont de Marsan, Frankrig
        • 205.452.33138 Boehringer Ingelheim Investigational Site
      • Montigny les Metz, Frankrig
        • 205.452.33005 Boehringer Ingelheim Investigational Site
      • Mundolsheim, Frankrig
        • 205.452.33163 Boehringer Ingelheim Investigational Site
      • Murs Erigne, Frankrig
        • 205.452.33109 Boehringer Ingelheim Investigational Site
      • Nantes, Frankrig
        • 205.452.33031 Boehringer Ingelheim Investigational Site
      • Nice, Frankrig
        • 205.452.33003 Boehringer Ingelheim Investigational Site
      • Oignies, Frankrig
        • 205.452.33108 Boehringer Ingelheim Investigational Site
      • Ollioules, Frankrig
        • 205.452.33014 Boehringer Ingelheim Investigational Site
      • Orthez, Frankrig
        • 205.452.33157 Boehringer Ingelheim Investigational Site
      • Parcay les Pins, Frankrig
        • 205.452.33112 Boehringer Ingelheim Investigational Site
      • Paris, Frankrig
        • 205.452.33001 Boehringer Ingelheim Investigational Site
      • Paris, Frankrig
        • 205.452.33051 Boehringer Ingelheim Investigational Site
      • Paris, Frankrig
        • 205.452.33082 Boehringer Ingelheim Investigational Site
      • Paris, Frankrig
        • 205.452.33165 Boehringer Ingelheim Investigational Site
      • Pont à Mousson, Frankrig
        • 205.452.33130 Boehringer Ingelheim Investigational Site
      • Quarouble, Frankrig
        • 205.452.33122 Boehringer Ingelheim Investigational Site
      • Reims, Frankrig
        • 205.452.33006 Boehringer Ingelheim Investigational Site
      • Rosiers d'Egletons, Frankrig
        • 205.452.33153 Boehringer Ingelheim Investigational Site
      • Rugles, Frankrig
        • 205.452.33161 Boehringer Ingelheim Investigational Site
      • Saint Alban Leysse, Frankrig
        • 205.452.33126 Boehringer Ingelheim Investigational Site
      • Saint Aulaire, Frankrig
        • 205.452.33140 Boehringer Ingelheim Investigational Site
      • Saint Avertin, Frankrig
        • 205.452.33052 Boehringer Ingelheim Investigational Site
      • Saint Léger des Bois, Frankrig
        • 205.452.33011 Boehringer Ingelheim Investigational Site
      • Saintes, Frankrig
        • 205.452.33002 Boehringer Ingelheim Investigational Site
      • Salies de Bearn, Frankrig
        • 205.452.33148 Boehringer Ingelheim Investigational Site
      • Savonnières, Frankrig
        • 205.452.33026 Boehringer Ingelheim Investigational Site
      • Segre, Frankrig
        • 205.452.33067 Boehringer Ingelheim Investigational Site
      • Serres Casset, Frankrig
        • 205.452.33040 Boehringer Ingelheim Investigational Site
      • Six Four les Plages, Frankrig
        • 205.452.33012 Boehringer Ingelheim Investigational Site
      • St Jouan des Guerets, Frankrig
        • 205.452.33160 Boehringer Ingelheim Investigational Site
      • St Sebastien sur Loire, Frankrig
        • 205.452.33079 Boehringer Ingelheim Investigational Site
      • Strasbourg, Frankrig
        • 205.452.33007 Boehringer Ingelheim Investigational Site
      • Strasbourg, Frankrig
        • 205.452.33033 Boehringer Ingelheim Investigational Site
      • Strasbourg, Frankrig
        • 205.452.33097 Boehringer Ingelheim Investigational Site
      • Strasbourg, Frankrig
        • 205.452.33101 Boehringer Ingelheim Investigational Site
      • Thouars, Frankrig
        • 205.452.33107 Boehringer Ingelheim Investigational Site
      • Tinténiac, Frankrig
        • 205.452.33116 Boehringer Ingelheim Investigational Site
      • Toulon, Frankrig
        • 205.452.33013 Boehringer Ingelheim Investigational Site
      • Tours, Frankrig
        • 205.452.33054 Boehringer Ingelheim Investigational Site
      • Tours, Frankrig
        • 205.452.33064 Boehringer Ingelheim Investigational Site
      • Tours, Frankrig
        • 205.452.33092 Boehringer Ingelheim Investigational Site
      • Tours, Frankrig
        • 205.452.33124 Boehringer Ingelheim Investigational Site
      • Vendôme, Frankrig
        • 205.452.33066 Boehringer Ingelheim Investigational Site
      • Vernoil, Frankrig
        • 205.452.33137 Boehringer Ingelheim Investigational Site
      • Vieux Condé, Frankrig
        • 205.452.33032 Boehringer Ingelheim Investigational Site
      • Vihiers, Frankrig
        • 205.452.33151 Boehringer Ingelheim Investigational Site
      • Villey St Etienne, Frankrig
        • 205.452.33077 Boehringer Ingelheim Investigational Site
      • Wattrelos, Frankrig
        • 205.452.33135 Boehringer Ingelheim Investigational Site
  • Georgien
      • Tbilisi, Georgien
        • 205.452.99501 Boehringer Ingelheim Investigational Site
      • Tbilisi, Georgien
        • 205.452.99502 Boehringer Ingelheim Investigational Site
      • Tbilisi, Georgien
        • 205.452.99503 Boehringer Ingelheim Investigational Site
      • Tbilisi, Georgien
        • 205.452.99504 Boehringer Ingelheim Investigational Site
      • Tbilisi, Georgien
        • 205.452.99505 Boehringer Ingelheim Investigational Site
      • Tbilisi, Georgien
        • 205.452.99506 Boehringer Ingelheim Investigational Site
      • Tbilisi, Georgien
        • 205.452.99507 Boehringer Ingelheim Investigational Site
  • Grækenland
      • Athens, Grækenland
        • 205.452.30002 Boehringer Ingelheim Investigational Site
      • Athens, Grækenland
        • 205.452.30003 Boehringer Ingelheim Investigational Site
      • Athens, Grækenland
        • 205.452.30008 Boehringer Ingelheim Investigational Site
      • Heraklion, Grækenland
        • 205.452.30001 Boehringer Ingelheim Investigational Site
      • Kalamaria, Grækenland
        • 205.452.30007 Boehringer Ingelheim Investigational Site
      • Kavala, Grækenland
        • 205.452.30010 Boehringer Ingelheim Investigational Site
      • Lamia, Grækenland
        • 205.452.30012 Boehringer Ingelheim Investigational Site
      • Nafplio, Grækenland
        • 205.452.30005 Boehringer Ingelheim Investigational Site
      • Rethymno, Grækenland
        • 205.452.30011 Boehringer Ingelheim Investigational Site
      • Serres, Grækenland
        • 205.452.30006 Boehringer Ingelheim Investigational Site
      • Thessaloniki, Grækenland
        • 205.452.30004 Boehringer Ingelheim Investigational Site
      • Thessaloniki, Grækenland
        • 205.452.30009 Boehringer Ingelheim Investigational Site
  • Guatemala
      • Guatemala, Guatemala
        • 205.452.50205 Boehringer Ingelheim Investigational Site
      • Guatemala, Guatemala
        • 205.452.50206 Boehringer Ingelheim Investigational Site
      • Nivel 12, Guatemala
        • 205.452.50203 Boehringer Ingelheim Investigational Site
      • Nivel Guatemala, Guatemala
        • 205.452.50201 Boehringer Ingelheim Investigational Site
      • Nivel Guatemala, Guatemala
        • 205.452.50202 Boehringer Ingelheim Investigational Site
      • Nivel Guatemala, Guatemala
        • 205.452.50204 Boehringer Ingelheim Investigational Site
      • Quetzaltenango, Guatemala
        • 205.452.50207 Boehringer Ingelheim Investigational Site
  • Holland
      • Almere, Holland
        • 205.452.31001 Boehringer Ingelheim Investigational Site
      • Andijk, Holland
        • 205.452.31008 Boehringer Ingelheim Investigational Site
      • Beek, Holland
        • 205.452.31002 Boehringer Ingelheim Investigational Site
      • Beek En Donk, Holland
        • 205.452.31012 Boehringer Ingelheim Investigational Site
      • Ermelo, Holland
        • 205.452.31003 Boehringer Ingelheim Investigational Site
      • Hoogwoud, Holland
        • 205.452.31010 Boehringer Ingelheim Investigational Site
      • Nijverdal, Holland
        • 205.452.31011 Boehringer Ingelheim Investigational Site
      • Oude Pekela, Holland
        • 205.452.31007 Boehringer Ingelheim Investigational Site
      • Roelofarendsveen, Holland
        • 205.452.31005 Boehringer Ingelheim Investigational Site
  • Indien
      • Ahmedabad, Indien
        • 205.452.91017 Boehringer Ingelheim Investigational Site
      • Chennai, Indien
        • 205.452.91018 Boehringer Ingelheim Investigational Site
      • Coimbatore, Indien
        • 205.452.91001 Boehringer Ingelheim Investigational Site
      • Coimbatore, Indien
        • 205.452.91002 Boehringer Ingelheim Investigational Site
      • Dadar(East), Indien
        • 205.452.91014 Boehringer Ingelheim Investigational Site
      • Hyderabad, Indien
        • 205.452.91005 Boehringer Ingelheim Investigational Site
      • Hyderabad, Indien
        • 205.452.91009 Boehringer Ingelheim Investigational Site
      • Jaipur, Indien
        • 205.452.91004 Boehringer Ingelheim Investigational Site
      • Jaipur, Indien
        • 205.452.91007 Boehringer Ingelheim Investigational Site
      • Jaipur, Indien
        • 205.452.91015 Boehringer Ingelheim Investigational Site
      • Jaipur, Indien
        • 205.452.91016 Boehringer Ingelheim Investigational Site
      • Karnataka, Indien
        • 205.452.91008 Boehringer Ingelheim Investigational Site
      • Maharashtra, Indien
        • 205.452.91006 Boehringer Ingelheim Investigational Site
      • Maharastra, Indien
        • 205.452.91003 Boehringer Ingelheim Investigational Site
      • Punjab, Indien
        • 205.452.91011 Boehringer Ingelheim Investigational Site
  • Irland
      • Co. Cork, Irland
        • 205.452.35307 Boehringer Ingelheim Investigational Site
      • Co. Tipperary, Irland
        • 205.452.35306 Boehringer Ingelheim Investigational Site
      • Co. Wexford, Irland
        • 205.452.35305 Boehringer Ingelheim Investigational Site
      • Dublin, Irland
        • 205.452.35302 Boehringer Ingelheim Investigational Site
      • Dublin 24, Irland
        • 205.452.35301 Boehringer Ingelheim Investigational Site
      • Limerick, Irland
        • 205.452.35303 Boehringer Ingelheim Investigational Site
      • Limerick, Irland
        • 205.452.35308 Boehringer Ingelheim Investigational Site
      • Offaly, Irland
        • 205.452.35304 Boehringer Ingelheim Investigational Site
  • Israel
      • Ashkelon, Israel
        • 205.452.97207 Boehringer Ingelheim Investigational Site
      • Beer Sheva, Israel
        • 205.452.97204 Boehringer Ingelheim Investigational Site
      • Haifa, Israel
        • 205.452.97208 Boehringer Ingelheim Investigational Site
      • Jerusalem, Israel
        • 205.452.97202 Boehringer Ingelheim Investigational Site
      • Kfar Saba, Israel
        • 205.452.97206 Boehringer Ingelheim Investigational Site
      • Petach Tikva, Israel
        • 205.452.97203 Boehringer Ingelheim Investigational Site
      • Rehovot, Israel
        • 205.452.97201 Boehringer Ingelheim Investigational Site
      • Tel-Aviv, Israel
        • 205.452.97205 Boehringer Ingelheim Investigational Site
  • Italien
      • Arenzano (ge), Italien
        • 205.452.39003 Boehringer Ingelheim Investigational Site
      • Ascoli Piceno, Italien
        • 205.452.39019 Boehringer Ingelheim Investigational Site
      • Avellino, Italien
        • 205.452.39016 Boehringer Ingelheim Investigational Site
      • Benevento, Italien
        • 205.452.39007 Boehringer Ingelheim Investigational Site
      • Brescia, Italien
        • 205.452.39024 Boehringer Ingelheim Investigational Site
      • Busto Arsizio (va), Italien
        • 205.452.39029 Boehringer Ingelheim Investigational Site
      • Cagliari, Italien
        • 205.452.39011 Boehringer Ingelheim Investigational Site
      • Cagliari, Italien
        • 205.452.39013 Boehringer Ingelheim Investigational Site
      • Cagliari, Italien
        • 205.452.39020 Boehringer Ingelheim Investigational Site
      • Catanzaro, Italien
        • 205.452.39015 Boehringer Ingelheim Investigational Site
      • Chieti Scalo, Italien
        • 205.452.39006 Boehringer Ingelheim Investigational Site
      • Firenze, Italien
        • 205.452.39001 Boehringer Ingelheim Investigational Site
      • Monza, Italien
        • 205.452.39021 Boehringer Ingelheim Investigational Site
      • Napoli, Italien
        • 205.452.39014 Boehringer Ingelheim Investigational Site
      • Orbassano (to), Italien
        • 205.452.39012 Boehringer Ingelheim Investigational Site
      • Orbassano (to), Italien
        • 205.452.39026 Boehringer Ingelheim Investigational Site
      • Palermo, Italien
        • 205.452.39010 Boehringer Ingelheim Investigational Site
      • Parma, Italien
        • 205.452.39005 Boehringer Ingelheim Investigational Site
      • Perugia, Italien
        • 205.452.39009 Boehringer Ingelheim Investigational Site
      • Prato, Italien
        • 205.452.39002 Boehringer Ingelheim Investigational Site
      • Reggio Emilia, Italien
        • 205.452.39030 Boehringer Ingelheim Investigational Site
      • Roma, Italien
        • 205.452.39004 Boehringer Ingelheim Investigational Site
      • Roma, Italien
        • 205.452.39017 Boehringer Ingelheim Investigational Site
      • Roma, Italien
        • 205.452.39027 Boehringer Ingelheim Investigational Site
      • Treviso, Italien
        • 205.452.39023 Boehringer Ingelheim Investigational Site
  • Kalkun
      • Adana, Kalkun
        • 205.452.90001 Boehringer Ingelheim Investigational Site
      • Ankara, Kalkun
        • 205.452.90008 Boehringer Ingelheim Investigational Site
      • Ankara, Kalkun
        • 205.452.90013 Boehringer Ingelheim Investigational Site
      • Antalya, Kalkun
        • 205.452.90005 Boehringer Ingelheim Investigational Site
      • Aydin, Kalkun
        • 205.452.90018 Boehringer Ingelheim Investigational Site
      • Bolu, Kalkun
        • 205.452.90003 Boehringer Ingelheim Investigational Site
      • Edirne, Kalkun
        • 205.452.90006 Boehringer Ingelheim Investigational Site
      • Erzurum, Kalkun
        • 205.452.90010 Boehringer Ingelheim Investigational Site
      • Hatay, Kalkun
        • 205.452.90019 Boehringer Ingelheim Investigational Site
      • Istanbul, Kalkun
        • 205.452.90017 Boehringer Ingelheim Investigational Site
      • Istanbul, Kalkun
        • 205.452.90020 Boehringer Ingelheim Investigational Site
      • Istanbul, Kalkun
        • 205.452.90021 Boehringer Ingelheim Investigational Site
      • Izmir, Kalkun
        • 205.452.90015 Boehringer Ingelheim Investigational Site
      • Izmir, Kalkun
        • 205.452.90016 Boehringer Ingelheim Investigational Site
      • Izmir, Kalkun
        • 205.452.90022 Boehringer Ingelheim Investigational Site
      • Malatya, Kalkun
        • 205.452.90007 Boehringer Ingelheim Investigational Site
  • Kina
      • Beijing, Kina
        • 205.452.86009 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 205.452.86010 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 205.452.86011 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 205.452.86012 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 205.452.86038 Boehringer Ingelheim Investigational Site
      • Changchun, Kina
        • 205.452.86026 Boehringer Ingelheim Investigational Site
      • Changsha, Kina
        • 205.452.86024 Boehringer Ingelheim Investigational Site
      • Changsha, Kina
        • 205.452.86025 Boehringer Ingelheim Investigational Site
      • Chengdu, Kina
        • 205.452.86021 Boehringer Ingelheim Investigational Site
      • Chengdu, Kina
        • 205.452.86032 Boehringer Ingelheim Investigational Site
      • Chongqing, Kina
        • 205.452.86034 Boehringer Ingelheim Investigational Site
      • Chongqing, Kina
        • 205.452.86035 Boehringer Ingelheim Investigational Site
      • Chongqing, Kina
        • 205.452.86036 Boehringer Ingelheim Investigational Site
      • Foshan, Kina
        • 205.452.86020 Boehringer Ingelheim Investigational Site
      • Guangzhou, Kina
        • 205.452.86001 Boehringer Ingelheim Investigational Site
      • Guangzhou, Kina
        • 205.452.86004 Boehringer Ingelheim Investigational Site
      • Guangzhou, Kina
        • 205.452.86005 Boehringer Ingelheim Investigational Site
      • Guangzhou, Kina
        • 205.452.86019 Boehringer Ingelheim Investigational Site
      • Guangzhou, Kina
        • 205.452.86028 Boehringer Ingelheim Investigational Site
      • Haikou, Kina
        • 205.452.86030 Boehringer Ingelheim Investigational Site
      • Hangzhou, Kina
        • 205.452.86007 Boehringer Ingelheim Investigational Site
      • Hangzhou, Kina
        • 205.452.86008 Boehringer Ingelheim Investigational Site
      • Nan Ning, Kina
        • 205.452.86029 Boehringer Ingelheim Investigational Site
      • Nanchang, Kina
        • 205.452.86037 Boehringer Ingelheim Investigational Site
      • Nanjing, Kina
        • 205.452.86022 Boehringer Ingelheim Investigational Site
      • Qingdao, Kina
        • 205.452.86027 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 205.452.86002 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 205.452.86003 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 205.452.86018 Boehringer Ingelheim Investigational Site
      • Shenyang, Kina
        • 205.452.86014 Boehringer Ingelheim Investigational Site
      • Shenyang, Kina
        • 205.452.86015 Boehringer Ingelheim Investigational Site
      • Suzhou, Kina
        • 205.452.86006 Boehringer Ingelheim Investigational Site
      • Tianjin, Kina
        • 205.452.86033 Boehringer Ingelheim Investigational Site
      • Wuhan, Kina
        • 205.452.86031 Boehringer Ingelheim Investigational Site
      • Xi'An, Kina
        • 205.452.86016 Boehringer Ingelheim Investigational Site
      • Xi'An, Kina
        • 205.452.86017 Boehringer Ingelheim Investigational Site
  • Korea, Republikken
      • Bucheon, Korea, Republikken
        • 205.452.82008 Boehringer Ingelheim Investigational Site
      • Busan, Korea, Republikken
        • 205.452.82002 Boehringer Ingelheim Investigational Site
      • Busan, Korea, Republikken
        • 205.452.82012 Boehringer Ingelheim Investigational Site
      • Daegu, Korea, Republikken
        • 205.452.82010 Boehringer Ingelheim Investigational Site
      • Daejoen, Korea, Republikken
        • 205.452.82016 Boehringer Ingelheim Investigational Site
      • Gangwon-Do, Korea, Republikken
        • 205.452.82009 Boehringer Ingelheim Investigational Site
      • Goyang, Korea, Republikken
        • 205.452.82017 Boehringer Ingelheim Investigational Site
      • Gwangju, Korea, Republikken
        • 205.452.82004 Boehringer Ingelheim Investigational Site
      • Incheon, Korea, Republikken
        • 205.452.82005 Boehringer Ingelheim Investigational Site
      • Jeonju, Korea, Republikken
        • 205.452.82020 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 205.452.82001 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 205.452.82003 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 205.452.82006 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 205.452.82007 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 205.452.82011 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 205.452.82013 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 205.452.82014 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 205.452.82015 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 205.452.82018 Boehringer Ingelheim Investigational Site
      • Uijeongbu, Korea, Republikken
        • 205.452.82019 Boehringer Ingelheim Investigational Site
  • Kroatien
      • Cakovec, Kroatien
        • 205.452.38512 Boehringer Ingelheim Investigational Site
      • Dubrovnik, Kroatien
        • 205.452.38508 Boehringer Ingelheim Investigational Site
      • Osijek, Kroatien
        • 205.452.38510 Boehringer Ingelheim Investigational Site
      • Rijeka, Kroatien
        • 205.452.38501 Boehringer Ingelheim Investigational Site
      • Sisak, Kroatien
        • 205.452.38506 Boehringer Ingelheim Investigational Site
      • Split, Kroatien
        • 205.452.38502 Boehringer Ingelheim Investigational Site
      • Split, Kroatien
        • 205.452.38503 Boehringer Ingelheim Investigational Site
      • Zagreb, Kroatien
        • 205.452.38504 Boehringer Ingelheim Investigational Site
      • Zagreb, Kroatien
        • 205.452.38505 Boehringer Ingelheim Investigational Site
      • Zagreb, Kroatien
        • 205.452.38507 Boehringer Ingelheim Investigational Site
      • Zagreb, Kroatien
        • 205.452.38509 Boehringer Ingelheim Investigational Site
      • Zagreb, Kroatien
        • 205.452.38511 Boehringer Ingelheim Investigational Site
  • Letland
      • Daugavpils, Letland
        • 205.452.37106 Boehringer Ingelheim Investigational Site
      • Daugavpils, Letland
        • 205.452.37107 Boehringer Ingelheim Investigational Site
      • Daugavpils, Letland
        • 205.452.37108 Boehringer Ingelheim Investigational Site
      • Kraslava, Letland
        • 205.452.37102 Boehringer Ingelheim Investigational Site
      • Riga, Letland
        • 205.452.37104 Boehringer Ingelheim Investigational Site
      • Riga, Letland
        • 205.452.37105 Boehringer Ingelheim Investigational Site
      • Riga, Letland
        • 205.452.37109 Boehringer Ingelheim Investigational Site
      • Riga, Letland
        • 205.452.37110 Boehringer Ingelheim Investigational Site
      • Talsi, Letland
        • 205.452.37101 Boehringer Ingelheim Investigational Site
      • Valmiera, Letland
        • 205.452.37103 Boehringer Ingelheim Investigational Site
  • Litauen
      • Alytus, Litauen
        • 205.452.37003 Boehringer Ingelheim Investigational Site
      • Kaunas, Litauen
        • 205.452.37001 Boehringer Ingelheim Investigational Site
      • Kaunas, Litauen
        • 205.452.37002 Boehringer Ingelheim Investigational Site
      • Klaipeda, Litauen
        • 205.452.37005 Boehringer Ingelheim Investigational Site
      • Siauliai, Litauen
        • 205.452.37007 Boehringer Ingelheim Investigational Site
      • Utena, Litauen
        • 205.452.37011 Boehringer Ingelheim Investigational Site
      • Vilnius, Litauen
        • 205.452.37004 Boehringer Ingelheim Investigational Site
      • Vilnius, Litauen
        • 205.452.37008 Boehringer Ingelheim Investigational Site
      • Vilnius, Litauen
        • 205.452.37010 Boehringer Ingelheim Investigational Site
  • Malaysia
      • Johor Bahru, Malaysia
        • 205.452.60006 Boehringer Ingelheim Investigational Site
      • Kuala Lumpur, Malaysia
        • 205.452.60001 Boehringer Ingelheim Investigational Site
      • Kuala Lumpur, Malaysia
        • 205.452.60002 Boehringer Ingelheim Investigational Site
      • Kuala Lumpur, Malaysia
        • 205.452.60004 Boehringer Ingelheim Investigational Site
      • Pahang, Malaysia
        • 205.452.60008 Boehringer Ingelheim Investigational Site
      • Sarawak, Malaysia
        • 205.452.60005 Boehringer Ingelheim Investigational Site
      • Selangor, Malaysia
        • 205.452.60009 Boehringer Ingelheim Investigational Site
      • Terengganu, Malaysia
        • 205.452.60007 Boehringer Ingelheim Investigational Site
  • Mexico
      • Aguascalientes, Mexico
        • 205.452.52004 Boehringer Ingelheim Investigational Site
      • Distrito Federal, Mexico
        • 205.452.52007 Boehringer Ingelheim Investigational Site
      • Guadalajara, Mexico
        • 205.452.52005 Boehringer Ingelheim Investigational Site
      • Monte Rey, Mexico
        • 205.452.52002 Boehringer Ingelheim Investigational Site
      • México, Mexico
        • 205.452.52001 Boehringer Ingelheim Investigational Site
      • Zona Río, Mexico
        • 205.452.52003 Boehringer Ingelheim Investigational Site
  • New Zealand
      • Christchurch, New Zealand
        • 205.452.64004 Boehringer Ingelheim Investigational Site
      • Dunedin, New Zealand
        • 205.452.64003 Boehringer Ingelheim Investigational Site
      • Newtown Wellington NZ, New Zealand
        • 205.452.64002 Boehringer Ingelheim Investigational Site
      • Tauranga, New Zealand
        • 205.452.64001 Boehringer Ingelheim Investigational Site
  • Norge
      • Drammen, Norge
        • 205.452.47008 Boehringer Ingelheim Investigational Site
      • Fredrikstad, Norge
        • 205.452.47009 Boehringer Ingelheim Investigational Site
      • Hønefoss, Norge
        • 205.452.47001 Boehringer Ingelheim Investigational Site
      • Kløfta, Norge
        • 205.452.47010 Boehringer Ingelheim Investigational Site
      • Kolbjørnsvik, Norge
        • 205.452.47007 Boehringer Ingelheim Investigational Site
      • Løvenstad, Norge
        • 205.452.47005 Boehringer Ingelheim Investigational Site
      • Oslo, Norge
        • 205.452.47002 Boehringer Ingelheim Investigational Site
      • Oslo, Norge
        • 205.452.47003 Boehringer Ingelheim Investigational Site
      • Oslo, Norge
        • 205.452.47011 Boehringer Ingelheim Investigational Site
      • Sandvika, Norge
        • 205.452.47012 Boehringer Ingelheim Investigational Site
      • Svelvik, Norge
        • 205.452.47004 Boehringer Ingelheim Investigational Site
      • Trollåsen, Norge
        • 205.452.47006 Boehringer Ingelheim Investigational Site
  • Panama
      • Carrasquilla, Panama
        • 205.452.50703 Boehringer Ingelheim Investigational Site
      • Marbella, Panama
        • 205.452.50701 Boehringer Ingelheim Investigational Site
      • Marbella, Panama
        • 205.452.50702 Boehringer Ingelheim Investigational Site
  • Peru
      • Bellavista, Peru
        • 205.452.51002 Boehringer Ingelheim Investigational Site
      • Cusco, Peru
        • 205.452.51003 Boehringer Ingelheim Investigational Site
      • Jesús Maria, Peru
        • 205.452.51004 Boehringer Ingelheim Investigational Site
      • Jesús María, Peru
        • 205.452.51007 Boehringer Ingelheim Investigational Site
      • Lima, Peru
        • 205.452.51005 Boehringer Ingelheim Investigational Site
      • San Isidro, Peru
        • 205.452.51001 Boehringer Ingelheim Investigational Site
      • San Martin de Porres, Peru
        • 205.452.51006 Boehringer Ingelheim Investigational Site
  • Polen
      • Babice, Polen
        • 205.452.48031 Boehringer Ingelheim Investigational Site
      • Bialystok, Polen
        • 205.452.48003 Boehringer Ingelheim Investigational Site
      • Bialystok, Polen
        • 205.452.48011 Boehringer Ingelheim Investigational Site
      • Bydgoszcz, Polen
        • 205.452.48014 Boehringer Ingelheim Investigational Site
      • Checiny, Polen
        • 205.452.48008 Boehringer Ingelheim Investigational Site
      • Gdansk, Polen
        • 205.452.48016 Boehringer Ingelheim Investigational Site
      • Gdynia, Polen
        • 205.452.48019 Boehringer Ingelheim Investigational Site
      • Gorzow Wlkp, Polen
        • 205.452.48037 Boehringer Ingelheim Investigational Site
      • Ilawa, Polen
        • 205.452.48015 Boehringer Ingelheim Investigational Site
      • Katowice, Polen
        • 205.452.48033 Boehringer Ingelheim Investigational Site
      • Katowice, Polen
        • 205.452.48039 Boehringer Ingelheim Investigational Site
      • Katowice, Polen
        • 205.452.48044 Boehringer Ingelheim Investigational Site
      • Krakow, Polen
        • 205.452.48009 Boehringer Ingelheim Investigational Site
      • Krakow, Polen
        • 205.452.48021 Boehringer Ingelheim Investigational Site
      • Krakow, Polen
        • 205.452.48029 Boehringer Ingelheim Investigational Site
      • Krakow, Polen
        • 205.452.48030 Boehringer Ingelheim Investigational Site
      • Krakow, Polen
        • 205.452.48048 Boehringer Ingelheim Investigational Site
      • Libiaz, Polen
        • 205.452.48043 Boehringer Ingelheim Investigational Site
      • Lodz, Polen
        • 205.452.48002 Boehringer Ingelheim Investigational Site
      • Lodz, Polen
        • 205.452.48051 Boehringer Ingelheim Investigational Site
      • Lodz, Polen
        • 205.452.48056 Boehringer Ingelheim Investigational Site
      • Lodz, Polen
        • 205.452.48059 Boehringer Ingelheim Investigational Site
      • Olsztyn, Polen
        • 205.452.48018 Boehringer Ingelheim Investigational Site
      • Ostrow Wielkopolska, Polen
        • 205.452.48025 Boehringer Ingelheim Investigational Site
      • Piaseczno, Polen
        • 205.452.48012 Boehringer Ingelheim Investigational Site
      • Piaseczno, Polen
        • 205.452.48040 Boehringer Ingelheim Investigational Site
      • Poznan, Polen
        • 205.452.48026 Boehringer Ingelheim Investigational Site
      • Poznan, Polen
        • 205.452.48027 Boehringer Ingelheim Investigational Site
      • Poznan, Polen
        • 205.452.48058 Boehringer Ingelheim Investigational Site
      • Rokietnica, Polen
        • 205.452.48060 Boehringer Ingelheim Investigational Site
      • Skierniewice, Polen
        • 205.452.48001 Boehringer Ingelheim Investigational Site
      • Slawkow, Polen
        • 205.452.48032 Boehringer Ingelheim Investigational Site
      • Szczecin, Polen
        • 205.452.48036 Boehringer Ingelheim Investigational Site
      • Tarnow, Polen
        • 205.452.48045 Boehringer Ingelheim Investigational Site
      • Tczew, Polen
        • 205.452.48057 Boehringer Ingelheim Investigational Site
      • Torun, Polen
        • 205.452.48004 Boehringer Ingelheim Investigational Site
      • Tranow, Polen
        • 205.452.48007 Boehringer Ingelheim Investigational Site
      • Turek, Polen
        • 205.452.48053 Boehringer Ingelheim Investigational Site
      • Warsaw, Polen
        • 205.452.48034 Boehringer Ingelheim Investigational Site
      • Warszawa, Polen
        • 205.452.48042 Boehringer Ingelheim Investigational Site
      • Warszawa, Polen
        • 205.452.48049 Boehringer Ingelheim Investigational Site
      • Wolomin, Polen
        • 205.452.48017 Boehringer Ingelheim Investigational Site
      • Wroclaw, Polen
        • 205.452.48006 Boehringer Ingelheim Investigational Site
      • Wroclaw, Polen
        • 205.452.48028 Boehringer Ingelheim Investigational Site
      • Wroclaw, Polen
        • 205.452.48035 Boehringer Ingelheim Investigational Site
      • Wroclaw, Polen
        • 205.452.48038 Boehringer Ingelheim Investigational Site
      • Zakopane, Polen
        • 205.452.48022 Boehringer Ingelheim Investigational Site
  • Portugal
      • Amadora, Portugal
        • 205.452.35103 Boehringer Ingelheim Investigational Site
      • Coimbra, Portugal
        • 205.452.35102 Boehringer Ingelheim Investigational Site
      • Lisboa, Portugal
        • 205.452.35107 Boehringer Ingelheim Investigational Site
      • Lisboa, Portugal
        • 205.452.35108 Boehringer Ingelheim Investigational Site
      • Matosinhos, Portugal
        • 205.452.35101 Boehringer Ingelheim Investigational Site
      • Penafiel, Portugal
        • 205.452.35105 Boehringer Ingelheim Investigational Site
      • Vila Nova de Gaia, Portugal
        • 205.452.35106 Boehringer Ingelheim Investigational Site
      • Viseu, Portugal
        • 205.452.35104 Boehringer Ingelheim Investigational Site
  • Puerto Rico
      • Ponce, Puerto Rico
        • 205.452.01177 Boehringer Ingelheim Investigational Site
      • San Juan, Puerto Rico
        • 205.452.01162 Boehringer Ingelheim Investigational Site
  • Rumænien
      • Brasov, Rumænien
        • 205.452.40008 Boehringer Ingelheim Investigational Site
      • Brasov, Rumænien
        • 205.452.40012 Boehringer Ingelheim Investigational Site
      • Bucharest, Rumænien
        • 205.452.40001 Boehringer Ingelheim Investigational Site
      • Bucharest, Rumænien
        • 205.452.40003 Boehringer Ingelheim Investigational Site
      • Bucharest, Rumænien
        • 205.452.40004 Boehringer Ingelheim Investigational Site
      • Bucharest, Rumænien
        • 205.452.40007 Boehringer Ingelheim Investigational Site
      • Bucharest, Rumænien
        • 205.452.40009 Boehringer Ingelheim Investigational Site
      • Bucharest, Rumænien
        • 205.452.40013 Boehringer Ingelheim Investigational Site
      • Bucuresti, Rumænien
        • 205.452.40002 Boehringer Ingelheim Investigational Site
      • Constanta, Rumænien
        • 205.452.40011 Boehringer Ingelheim Investigational Site
      • Craiova, Rumænien
        • 205.452.40006 Boehringer Ingelheim Investigational Site
  • Schweiz
      • Ascona, Schweiz
        • 205.452.41003 Boehringer Ingelheim Investigational Site
      • Basel, Schweiz
        • 205.452.41004 Boehringer Ingelheim Investigational Site
      • Bern, Schweiz
        • 205.452.41016 Boehringer Ingelheim Investigational Site
      • Glarus, Schweiz
        • 205.452.41012 Boehringer Ingelheim Investigational Site
      • Gossau, Schweiz
        • 205.452.41001 Boehringer Ingelheim Investigational Site
      • Liestal, Schweiz
        • 205.452.41015 Boehringer Ingelheim Investigational Site
      • Locarno, Schweiz
        • 205.452.41010 Boehringer Ingelheim Investigational Site
      • Lugano, Schweiz
        • 205.452.41011 Boehringer Ingelheim Investigational Site
      • Spiez, Schweiz
        • 205.452.41007 Boehringer Ingelheim Investigational Site
      • St. Gallen, Schweiz
        • 205.452.41002 Boehringer Ingelheim Investigational Site
      • St. Gallen, Schweiz
        • 205.452.41009 Boehringer Ingelheim Investigational Site
      • Zürich, Schweiz
        • 205.452.41013 Boehringer Ingelheim Investigational Site
      • Zürich, Schweiz
        • 205.452.41014 Boehringer Ingelheim Investigational Site
  • Serbien
      • Belgrade, Serbien
        • 205.452.38103 Boehringer Ingelheim Investigational Site
      • Belgrade, Serbien
        • 205.452.38104 Boehringer Ingelheim Investigational Site
      • Belgrade, Serbien
        • 205.452.38106 Boehringer Ingelheim Investigational Site
      • Belgrade, Serbien
        • 205.452.38107 Boehringer Ingelheim Investigational Site
      • Kragujevac, Serbien
        • 205.452.38102 Boehringer Ingelheim Investigational Site
      • Nis, Serbien
        • 205.452.38105 Boehringer Ingelheim Investigational Site
      • Sremska Kamenica, Serbien
        • 205.452.38101 Boehringer Ingelheim Investigational Site
  • Slovakiet
      • Bardejov, Slovakiet
        • 205.452.42103 Boehringer Ingelheim Investigational Site
      • Bratislava, Slovakiet
        • 205.452.42107 Boehringer Ingelheim Investigational Site
      • Humenne, Slovakiet
        • 205.452.42102 Boehringer Ingelheim Investigational Site
      • Kosice, Slovakiet
        • 205.452.42105 Boehringer Ingelheim Investigational Site
      • Kosice, Slovakiet
        • 205.452.42111 Boehringer Ingelheim Investigational Site
      • Kosice, Slovakiet
        • 205.452.42113 Boehringer Ingelheim Investigational Site
      • Levice, Slovakiet
        • 205.452.42108 Boehringer Ingelheim Investigational Site
      • Martin, Slovakiet
        • 205.452.42109 Boehringer Ingelheim Investigational Site
      • Poprad, Slovakiet
        • 205.452.42112 Boehringer Ingelheim Investigational Site
      • Presov, Slovakiet
        • 205.452.42101 Boehringer Ingelheim Investigational Site
      • Rimavska Sobota, Slovakiet
        • 205.452.42104 Boehringer Ingelheim Investigational Site
      • Spisska Nova Ves, Slovakiet
        • 205.452.42106 Boehringer Ingelheim Investigational Site
      • Sturovo, Slovakiet
        • 205.452.42110 Boehringer Ingelheim Investigational Site
  • Spanien
      • Badajoz, Spanien
        • 205.452.34018 Boehringer Ingelheim Investigational Site
      • Badalona (Barcelona), Spanien
        • 205.452.34021 Boehringer Ingelheim Investigational Site
      • Barcelona, Spanien
        • 205.452.34010 Boehringer Ingelheim Investigational Site
      • Barcelona, Spanien
        • 205.452.34025 Boehringer Ingelheim Investigational Site
      • Centelles, Spanien
        • 205.452.34027 Boehringer Ingelheim Investigational Site
      • Cáceres, Spanien
        • 205.452.34015 Boehringer Ingelheim Investigational Site
      • Elda, Spanien
        • 205.452.34016 Boehringer Ingelheim Investigational Site
      • Hospitalet de Llobregat, Spanien
        • 205.452.34008 Boehringer Ingelheim Investigational Site
      • Lugo, Spanien
        • 205.452.34026 Boehringer Ingelheim Investigational Site
      • Madrid, Spanien
        • 205.452.34011 Boehringer Ingelheim Investigational Site
      • Madrid, Spanien
        • 205.452.34019 Boehringer Ingelheim Investigational Site
      • Málaga, Spanien
        • 205.452.34020 Boehringer Ingelheim Investigational Site
      • Mérida, Spanien
        • 205.452.34002 Boehringer Ingelheim Investigational Site
      • Plasencia, Spanien
        • 205.452.34017 Boehringer Ingelheim Investigational Site
      • Pozuelo de Alarcón, Spanien
        • 205.452.34001 Boehringer Ingelheim Investigational Site
      • San Juan de Alicante, Spanien
        • 205.452.34024 Boehringer Ingelheim Investigational Site
      • Santander, Spanien
        • 205.452.34003 Boehringer Ingelheim Investigational Site
      • Terrassa (Barcelona), Spanien
        • 205.452.34005 Boehringer Ingelheim Investigational Site
      • Torrevieja, Spanien
        • 205.452.34007 Boehringer Ingelheim Investigational Site
      • Valencia, Spanien
        • 205.452.34012 Boehringer Ingelheim Investigational Site
      • Valladolid, Spanien
        • 205.452.34013 Boehringer Ingelheim Investigational Site
      • Vic (Barcelona), Spanien
        • 205.452.34009 Boehringer Ingelheim Investigational Site
      • Vilanova i la Geltrú, Spanien
        • 205.452.34023 Boehringer Ingelheim Investigational Site
      • Zaragoza, Spanien
        • 205.452.34004 Boehringer Ingelheim Investigational Site
  • Sverige
      • Brämhult, Sverige
        • 205.452.46005 Boehringer Ingelheim Investigational Site
      • Eksjö, Sverige
        • 205.452.46014 Boehringer Ingelheim Investigational Site
      • Gullspång, Sverige
        • 205.452.46012 Boehringer Ingelheim Investigational Site
      • Göteborg, Sverige
        • 205.452.46013 Boehringer Ingelheim Investigational Site
      • Höllviken, Sverige
        • 205.452.46001 Boehringer Ingelheim Investigational Site
      • Järfälla, Sverige
        • 205.452.46008 Boehringer Ingelheim Investigational Site
      • Kil, Sverige
        • 205.452.46009 Boehringer Ingelheim Investigational Site
      • Lidingö, Sverige
        • 205.452.46007 Boehringer Ingelheim Investigational Site
      • Luleå, Sverige
        • 205.452.46003 Boehringer Ingelheim Investigational Site
      • Sigtuna, Sverige
        • 205.452.46010 Boehringer Ingelheim Investigational Site
      • Solna, Sverige
        • 205.452.46002 Boehringer Ingelheim Investigational Site
      • Uddevalla, Sverige
        • 205.452.46011 Boehringer Ingelheim Investigational Site
      • Örebro, Sverige
        • 205.452.46006 Boehringer Ingelheim Investigational Site
  • Sydafrika
      • Amanzimtoti, Sydafrika
        • 205.452.27013 Boehringer Ingelheim Investigational Site
      • Bellville, Sydafrika
        • 205.452.27002 Boehringer Ingelheim Investigational Site
      • Bloemfontein, Sydafrika
        • 205.452.27010 Boehringer Ingelheim Investigational Site
      • Cape Town, Sydafrika
        • 205.452.27001 Boehringer Ingelheim Investigational Site
      • Cape Town, Sydafrika
        • 205.452.27004 Boehringer Ingelheim Investigational Site
      • Cape Town, Sydafrika
        • 205.452.27008 Boehringer Ingelheim Investigational Site
      • Cape Town, Sydafrika
        • 205.452.27011 Boehringer Ingelheim Investigational Site
      • Cape Town, Sydafrika
        • 205.452.27012 Boehringer Ingelheim Investigational Site
      • Centurion, Sydafrika
        • 205.452.27006 Boehringer Ingelheim Investigational Site
      • Durban, Sydafrika
        • 205.452.27003 Boehringer Ingelheim Investigational Site
      • Johannesburg, Sydafrika
        • 205.452.27014 Boehringer Ingelheim Investigational Site
      • Pretoria, Sydafrika
        • 205.452.27005 Boehringer Ingelheim Investigational Site
      • Pretoria, Sydafrika
        • 205.452.27009 Boehringer Ingelheim Investigational Site
      • Somerset West, Sydafrika
        • 205.452.27007 Boehringer Ingelheim Investigational Site
  • Taiwan
      • Changhua, Taiwan
        • 205.452.88607 Boehringer Ingelheim Investigational Site
      • Chia-Yi, Taiwan
        • 205.452.88614 Boehringer Ingelheim Investigational Site
      • Kaohsiung, Taiwan
        • 205.452.88611 Boehringer Ingelheim Investigational Site
      • Kaohsiung City, Taiwan
        • 205.452.88608 Boehringer Ingelheim Investigational Site
      • Kaohsiung City, Taiwan
        • 205.452.88609 Boehringer Ingelheim Investigational Site
      • New Taipei, Taiwan
        • 205.452.88604 Boehringer Ingelheim Investigational Site
      • Taichung, Taiwan
        • 205.452.88605 Boehringer Ingelheim Investigational Site
      • Taichung, Taiwan
        • 205.452.88606 Boehringer Ingelheim Investigational Site
      • Taichung, Taiwan
        • 205.452.88612 Boehringer Ingelheim Investigational Site
      • Tainan, Taiwan
        • 205.452.88610 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 205.452.88602 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 205.452.88603 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 205.452.88613 Boehringer Ingelheim Investigational Site
      • Taoyuan County, Taiwan
        • 205.452.88601 Boehringer Ingelheim Investigational Site
  • Thailand
      • Chiang Mai, Thailand
        • 205.452.66004 Boehringer Ingelheim Investigational Site
      • Hatyai, Songkhla, Thailand
        • 205.452.66003 Boehringer Ingelheim Investigational Site
      • Khon Kaen, Thailand
        • 205.452.66002 Boehringer Ingelheim Investigational Site
      • Muang, Phitsanulok, Thailand
        • 205.452.66005 Boehringer Ingelheim Investigational Site
      • Nonthaburi, Thailand
        • 205.452.66001 Boehringer Ingelheim Investigational Site
  • Tunesien
      • Ariana, Tunesien
        • 205.452.21603 Boehringer Ingelheim Investigational Site
      • Ariana, Tunesien
        • 205.452.21605 Boehringer Ingelheim Investigational Site
      • Ariana, Tunesien
        • 205.452.21606 Boehringer Ingelheim Investigational Site
      • Ariana, Tunesien
        • 205.452.21607 Boehringer Ingelheim Investigational Site
      • Mahdia, Tunesien
        • 205.452.21610 Boehringer Ingelheim Investigational Site
      • Monastir, Tunesien
        • 205.452.21609 Boehringer Ingelheim Investigational Site
      • Nabeul, Tunesien
        • 205.452.21608 Boehringer Ingelheim Investigational Site
      • Tunis, Tunesien
        • 205.452.21601 Boehringer Ingelheim Investigational Site
      • Tunis, Tunesien
        • 205.452.21602 Boehringer Ingelheim Investigational Site
      • Tunis, Tunesien
        • 205.452.21604 Boehringer Ingelheim Investigational Site
  • Tyskland
      • Aschaffenburg, Tyskland
        • 205.452.49096 Boehringer Ingelheim Investigational Site
      • Augsburg, Tyskland
        • 205.452.49130 Boehringer Ingelheim Investigational Site
      • Augsburg, Tyskland
        • 205.452.49161 Boehringer Ingelheim Investigational Site
      • Backnang, Tyskland
        • 205.452.49001 Boehringer Ingelheim Investigational Site
      • Bad Kissingen, Tyskland
        • 205.452.49173 Boehringer Ingelheim Investigational Site
      • Bad Lippspringe, Tyskland
        • 205.452.49134 Boehringer Ingelheim Investigational Site
      • Bad Neustadt, Tyskland
        • 205.452.49082 Boehringer Ingelheim Investigational Site
      • Bad Wörishofen, Tyskland
        • 205.452.49058 Boehringer Ingelheim Investigational Site
      • Bamberg, Tyskland
        • 205.452.49145 Boehringer Ingelheim Investigational Site
      • Bensheim, Tyskland
        • 205.452.49072 Boehringer Ingelheim Investigational Site
      • Bergisch Gladbach, Tyskland
        • 205.452.49048 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49006 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49016 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49028 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49031 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49054 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49064 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49066 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49068 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49102 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49135 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49138 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49157 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49167 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49175 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 205.452.49180 Boehringer Ingelheim Investigational Site
      • Bonn, Tyskland
        • 205.452.49037 Boehringer Ingelheim Investigational Site
      • Bonn, Tyskland
        • 205.452.49118 Boehringer Ingelheim Investigational Site
      • Brake, Tyskland
        • 205.452.49083 Boehringer Ingelheim Investigational Site
      • Bruchsal, Tyskland
        • 205.452.49040 Boehringer Ingelheim Investigational Site
      • Celle, Tyskland
        • 205.452.49089 Boehringer Ingelheim Investigational Site
      • Cottbus, Tyskland
        • 205.452.49143 Boehringer Ingelheim Investigational Site
      • Deggendorf, Tyskland
        • 205.452.49119 Boehringer Ingelheim Investigational Site
      • Dillingen, Tyskland
        • 205.452.49151 Boehringer Ingelheim Investigational Site
      • Donaueschingen, Tyskland
        • 205.452.49117 Boehringer Ingelheim Investigational Site
      • Dortmund, Tyskland
        • 205.452.49015 Boehringer Ingelheim Investigational Site
      • Düren, Tyskland
        • 205.452.49008 Boehringer Ingelheim Investigational Site
      • Emden, Tyskland
        • 205.452.49098 Boehringer Ingelheim Investigational Site
      • Engelskirchen, Tyskland
        • 205.452.49003 Boehringer Ingelheim Investigational Site
      • Ense, Tyskland
        • 205.452.49024 Boehringer Ingelheim Investigational Site
      • Essen, Tyskland
        • 205.452.49168 Boehringer Ingelheim Investigational Site
      • Forchheim, Tyskland
        • 205.452.49104 Boehringer Ingelheim Investigational Site
      • Frankfurt, Tyskland
        • 205.452.49070 Boehringer Ingelheim Investigational Site
      • Frankfurt, Tyskland
        • 205.452.49147 Boehringer Ingelheim Investigational Site
      • Fulda, Tyskland
        • 205.452.49137 Boehringer Ingelheim Investigational Site
      • Föhren, Tyskland
        • 205.452.49133 Boehringer Ingelheim Investigational Site
      • Gelnhausen, Tyskland
        • 205.452.49107 Boehringer Ingelheim Investigational Site
      • Gütersloh, Tyskland
        • 205.452.49032 Boehringer Ingelheim Investigational Site
      • Hagen, Tyskland
        • 205.452.49026 Boehringer Ingelheim Investigational Site
      • Hagen, Tyskland
        • 205.452.49041 Boehringer Ingelheim Investigational Site
      • Hamburg, Tyskland
        • 205.452.49044 Boehringer Ingelheim Investigational Site
      • Hamburg, Tyskland
        • 205.452.49061 Boehringer Ingelheim Investigational Site
      • Hamburg, Tyskland
        • 205.452.49080 Boehringer Ingelheim Investigational Site
      • Hannover, Tyskland
        • 205.452.49038 Boehringer Ingelheim Investigational Site
      • Hannover, Tyskland
        • 205.452.49052 Boehringer Ingelheim Investigational Site
      • Hannover, Tyskland
        • 205.452.49094 Boehringer Ingelheim Investigational Site
      • Heidelberg, Tyskland
        • 205.452.49181 Boehringer Ingelheim Investigational Site
      • Heilbronn, Tyskland
        • 205.452.49116 Boehringer Ingelheim Investigational Site
      • Hemmingen, Tyskland
        • 205.452.49022 Boehringer Ingelheim Investigational Site
      • Höchstädt, Tyskland
        • 205.452.49007 Boehringer Ingelheim Investigational Site
      • Ingelheim, Tyskland
        • 205.452.49136 Boehringer Ingelheim Investigational Site
      • Karlsruhe, Tyskland
        • 205.452.49159 Boehringer Ingelheim Investigational Site
      • Kassel, Tyskland
        • 205.452.49027 Boehringer Ingelheim Investigational Site
      • Kaufbeuren, Tyskland
        • 205.452.49105 Boehringer Ingelheim Investigational Site
      • Koblenz, Tyskland
        • 205.452.49101 Boehringer Ingelheim Investigational Site
      • Käbschütztal-Krögis, Tyskland
        • 205.452.49047 Boehringer Ingelheim Investigational Site
      • Köln, Tyskland
        • 205.452.49146 Boehringer Ingelheim Investigational Site
      • Landsberg am Lech, Tyskland
        • 205.452.49114 Boehringer Ingelheim Investigational Site
      • Langen, Tyskland
        • 205.452.49169 Boehringer Ingelheim Investigational Site
      • Leipzig, Tyskland
        • 205.452.49017 Boehringer Ingelheim Investigational Site
      • Leipzig, Tyskland
        • 205.452.49035 Boehringer Ingelheim Investigational Site
      • Leipzig, Tyskland
        • 205.452.49113 Boehringer Ingelheim Investigational Site
      • Leipzig, Tyskland
        • 205.452.49139 Boehringer Ingelheim Investigational Site
      • Leipzig, Tyskland
        • 205.452.49172 Boehringer Ingelheim Investigational Site
      • Leonberg, Tyskland
        • 205.452.49110 Boehringer Ingelheim Investigational Site
      • Mannheim, Tyskland
        • 205.452.49088 Boehringer Ingelheim Investigational Site
      • Marburg, Tyskland
        • 205.452.49108 Boehringer Ingelheim Investigational Site
      • Marburg, Tyskland
        • 205.452.49122 Boehringer Ingelheim Investigational Site
      • Minden, Tyskland
        • 205.452.49055 Boehringer Ingelheim Investigational Site
      • München, Tyskland
        • 205.452.49025 Boehringer Ingelheim Investigational Site
      • München, Tyskland
        • 205.452.49131 Boehringer Ingelheim Investigational Site
      • Neumünster, Tyskland
        • 205.452.49023 Boehringer Ingelheim Investigational Site
      • Neuruppin, Tyskland
        • 205.452.49132 Boehringer Ingelheim Investigational Site
      • Neuwied, Tyskland
        • 205.452.49045 Boehringer Ingelheim Investigational Site
      • Oranienburg, Tyskland
        • 205.452.49062 Boehringer Ingelheim Investigational Site
      • Oschersleben, Tyskland
        • 205.452.49124 Boehringer Ingelheim Investigational Site
      • Paderborn, Tyskland
        • 205.452.49019 Boehringer Ingelheim Investigational Site
      • Potsdam, Tyskland
        • 205.452.49053 Boehringer Ingelheim Investigational Site
      • Potsdam, Tyskland
        • 205.452.49076 Boehringer Ingelheim Investigational Site
      • Radebeul, Tyskland
        • 205.452.49049 Boehringer Ingelheim Investigational Site
      • Rathenow, Tyskland
        • 205.452.49056 Boehringer Ingelheim Investigational Site
      • Raubach, Tyskland
        • 205.452.49009 Boehringer Ingelheim Investigational Site
      • Rehau, Tyskland
        • 205.452.49002 Boehringer Ingelheim Investigational Site
      • Reinfeld, Tyskland
        • 205.452.49142 Boehringer Ingelheim Investigational Site
      • Rhaunen, Tyskland
        • 205.452.49030 Boehringer Ingelheim Investigational Site
      • Rheine, Tyskland
        • 205.452.49184 Boehringer Ingelheim Investigational Site
      • Rodgau-Dudenhofen, Tyskland
        • 205.452.49077 Boehringer Ingelheim Investigational Site
      • Rüsselsheim, Tyskland
        • 205.452.49021 Boehringer Ingelheim Investigational Site
      • Rüsselsheim, Tyskland
        • 205.452.49091 Boehringer Ingelheim Investigational Site
      • Saarlouis, Tyskland
        • 205.452.49042 Boehringer Ingelheim Investigational Site
      • Schwetzingen, Tyskland
        • 205.452.49034 Boehringer Ingelheim Investigational Site
      • Solingen, Tyskland
        • 205.452.49013 Boehringer Ingelheim Investigational Site
      • Solingen, Tyskland
        • 205.452.49057 Boehringer Ingelheim Investigational Site
      • Tübingen, Tyskland
        • 205.452.49078 Boehringer Ingelheim Investigational Site
      • Ulm, Tyskland
        • 205.452.49099 Boehringer Ingelheim Investigational Site
      • Wallerfing, Tyskland
        • 205.452.49043 Boehringer Ingelheim Investigational Site
      • Wardenburg, Tyskland
        • 205.452.49067 Boehringer Ingelheim Investigational Site
      • Warendorf, Tyskland
        • 205.452.49165 Boehringer Ingelheim Investigational Site
      • Weinheim, Tyskland
        • 205.452.49051 Boehringer Ingelheim Investigational Site
      • Weyhe, Tyskland
        • 205.452.49127 Boehringer Ingelheim Investigational Site
      • Wiesloch, Tyskland
        • 205.452.49092 Boehringer Ingelheim Investigational Site
      • Witten, Tyskland
        • 205.452.49018 Boehringer Ingelheim Investigational Site
      • Witten, Tyskland
        • 205.452.49029 Boehringer Ingelheim Investigational Site
      • Wolfsburg, Tyskland
        • 205.452.49095 Boehringer Ingelheim Investigational Site
      • Zerbst, Tyskland
        • 205.452.49060 Boehringer Ingelheim Investigational Site
  • Ukraine
      • Crimea, Ukraine
        • 205.452.38028 Boehringer Ingelheim Investigational Site
      • Dnipropetrovks, Ukraine
        • 205.452.38024 Boehringer Ingelheim Investigational Site
      • Dnipropetrovsk, Ukraine
        • 205.452.38022 Boehringer Ingelheim Investigational Site
      • Dnyepropyetrovsk, Ukraine
        • 205.452.38034 Boehringer Ingelheim Investigational Site
      • Donetsk, Ukraine
        • 205.452.38002 Boehringer Ingelheim Investigational Site
      • Donetsk, Ukraine
        • 205.452.38020 Boehringer Ingelheim Investigational Site
      • Ivano-Frankivsk, Ukraine
        • 205.452.38011 Boehringer Ingelheim Investigational Site
      • Kharkiv, Ukraine
        • 205.452.38005 Boehringer Ingelheim Investigational Site
      • Kharkov, Ukraine
        • 205.452.38001 Boehringer Ingelheim Investigational Site
      • Kharkov, Ukraine
        • 205.452.38004 Boehringer Ingelheim Investigational Site
      • Kharkov, Ukraine
        • 205.452.38006 Boehringer Ingelheim Investigational Site
      • Kharkov, Ukraine
        • 205.452.38008 Boehringer Ingelheim Investigational Site
      • Kharkov, Ukraine
        • 205.452.38018 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 205.452.38003 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 205.452.38010 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 205.452.38012 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 205.452.38013 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 205.452.38015 Boehringer Ingelheim Investigational Site
      • Kiev, Ukraine
        • 205.452.38032 Boehringer Ingelheim Investigational Site
      • Nikolayev, Ukraine
        • 205.452.38026 Boehringer Ingelheim Investigational Site
      • Odesa, Ukraine
        • 205.452.38023 Boehringer Ingelheim Investigational Site
      • Odessa, Ukraine
        • 205.452.38027 Boehringer Ingelheim Investigational Site
      • Odessa, Ukraine
        • 205.452.38031 Boehringer Ingelheim Investigational Site
      • Simferopol, Ukraine
        • 205.452.38017 Boehringer Ingelheim Investigational Site
      • Vinnytsya, Ukraine
        • 205.452.38019 Boehringer Ingelheim Investigational Site
      • Zaporizhzhya, Ukraine
        • 205.452.38030 Boehringer Ingelheim Investigational Site
  • Ungarn
      • Baja, Ungarn
        • 205.452.36005 Boehringer Ingelheim Investigational Site
      • Budapest, Ungarn
        • 205.452.36004 Boehringer Ingelheim Investigational Site
      • Budapest, Ungarn
        • 205.452.36016 Boehringer Ingelheim Investigational Site
      • Budapest, Ungarn
        • 205.452.36030 Boehringer Ingelheim Investigational Site
      • Debrecen, Ungarn
        • 205.452.36007 Boehringer Ingelheim Investigational Site
      • Debrecen, Ungarn
        • 205.452.36013 Boehringer Ingelheim Investigational Site
      • Debrecen, Ungarn
        • 205.452.36015 Boehringer Ingelheim Investigational Site
      • Deszk, Ungarn
        • 205.452.36029 Boehringer Ingelheim Investigational Site
      • Dombovar, Ungarn
        • 205.452.36026 Boehringer Ingelheim Investigational Site
      • Erd, Ungarn
        • 205.452.36003 Boehringer Ingelheim Investigational Site
      • Farkasgyepü, Ungarn
        • 205.452.36008 Boehringer Ingelheim Investigational Site
      • Györ, Ungarn
        • 205.452.36020 Boehringer Ingelheim Investigational Site
      • Hajduböszörmeny, Ungarn
        • 205.452.36012 Boehringer Ingelheim Investigational Site
      • Hodmezovasarhely, Ungarn
        • 205.452.36023 Boehringer Ingelheim Investigational Site
      • Kaposvar, Ungarn
        • 205.452.36010 Boehringer Ingelheim Investigational Site
      • Kapuvar, Ungarn
        • 205.452.36018 Boehringer Ingelheim Investigational Site
      • Kecskemet, Ungarn
        • 205.452.36002 Boehringer Ingelheim Investigational Site
      • Makó, Ungarn
        • 205.452.36001 Boehringer Ingelheim Investigational Site
      • Mohacs, Ungarn
        • 205.452.36006 Boehringer Ingelheim Investigational Site
      • Mosonmagyarovar, Ungarn
        • 205.452.36022 Boehringer Ingelheim Investigational Site
      • Nagykanizsa, Ungarn
        • 205.452.36027 Boehringer Ingelheim Investigational Site
      • Nyiregyhaza, Ungarn
        • 205.452.36014 Boehringer Ingelheim Investigational Site
      • Pecs, Ungarn
        • 205.452.36009 Boehringer Ingelheim Investigational Site
      • Pecs, Ungarn
        • 205.452.36011 Boehringer Ingelheim Investigational Site
      • Siófok, Ungarn
        • 205.452.36028 Boehringer Ingelheim Investigational Site
      • Szarvas, Ungarn
        • 205.452.36021 Boehringer Ingelheim Investigational Site
      • Szeged, Ungarn
        • 205.452.36017 Boehringer Ingelheim Investigational Site
      • Tatabanya, Ungarn
        • 205.452.36024 Boehringer Ingelheim Investigational Site
      • Törökbálint, Ungarn
        • 205.452.36019 Boehringer Ingelheim Investigational Site
      • Törökbálint, Ungarn
        • 205.452.36025 Boehringer Ingelheim Investigational Site
  • Østrig
      • Feldbach, Østrig
        • 205.452.43002 Boehringer Ingelheim Investigational Site
      • Hallein, Østrig
        • 205.452.43003 Boehringer Ingelheim Investigational Site
      • Thalheim bei Wels, Østrig
        • 205.452.43005 Boehringer Ingelheim Investigational Site

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

40 år og ældre (VOKSEN, OLDER_ADULT)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inklusionskriterier:

  1. Alle patienter skal underskrive et informeret samtykke i overensstemmelse med International Conference on Harmonization Good Clinical Practice (ICH-GCP) retningslinjer før deltagelse i forsøget, som omfatter udvaskning af medicin og restriktioner.
  2. Mandlige eller kvindelige patienter 40 år eller ældre.
  3. Patienter skal være nuværende eller tidligere rygere med en rygehistorie på ≥10 pakår. (Patienter, der aldrig har røget cigaretter, skal udelukkes)

  4. Alle patienter skal have diagnosen KOL (P06-12085), og skal opfylde følgende kriterier: Relativt stabil luftvejsobstruktion med en postbronkodilaterende FEV1 ≤ 70 % af forudsagt normal og postbronkodilaterende FEV1/FVC ≤70 %.

    Lungefunktionstests (PFT'er) blev udført efter inhalation af 400 μg salbutamol/albuterol (foretrukket), men testning med enten 200 μg salbutamol/albuterol eller en kombination af salbutamol/albuterol med ipratropiumbromid (2 til 4 aktiveringer) var acceptabel. Andre korttidsvirkende beta-agonister, såsom terbutalin, kan være blevet brugt til testen. Den medicin, der blev brugt til testen, blev dokumenteret. Yderligere kan historiske data fra målinger inden for de seneste 6 måneder enten på stedet eller på et henvisningssted være blevet brugt (se afsnit 6.2.1 i CTP, som findes i bilag 16.1.1). Forsøgspersoner skulle ikke være blevet randomiseret til undersøgelsen uden tilgængelighed af spirometridata på det faktiske undersøgelsessted.

    Berettigelse til PFT-delstudie: For forsøgspersoner, der deltager i spirometri-delstudiet, er historiske data muligvis ikke blevet brugt til inklusion. Disse forsøgspersoner skal have kvalificeret sig i klinikken ved Besøg 1 efter at have udført en baseline-måling. Disse forsøgspersoner udførte en præ-dosis PFT, som blev efterfulgt af administration af 400 μg salbutamol/albuterol alene (ingen anden korttidsvirkende beta-agonist var tilladt), efterfulgt af en post-dosis PFT for kvalificering.

  5. Kan inhalere fra HandiHaler® og Respimat®-enhederne.

Ekskluderingskriterier:

  1. Andre væsentlige sygdomme end KOL. En signifikant sygdom defineres som en sygdom eller tilstand, der efter investigatorens opfattelse kan bringe patienten i fare på grund af deltagelse i undersøgelsen eller kan påvirke patientens mulighed for at deltage i undersøgelsen.
  2. Patienter med en nylig historie (dvs. seks måneder eller mindre) med myokardieinfarkt.
  3. Patienter med ustabil eller livstruende hjertearytmi, der kræver intervention eller ændring i lægemiddelbehandling i løbet af det sidste år.
  4. Hospitalsindlæggelse for hjertesvigt (New York Heart Association (NYHA) klasse III eller IV) i løbet af det seneste år.
  5. Kendt aktiv tuberkulose.
  6. Patienter med astma, cystisk fibrose, klinisk tydelig bronkiektasi, interstitiel lungesygdom eller pulmonal tromboembolisk sygdom.
  7. Anamnese med torakotomi med pulmonal resektion. Forsøgspersoner med en historie med thorakotomi af andre årsager skulle være blevet evalueret efter eksklusionskriterium 1.
  8. Forsøgspersonen planlagde at gennemgå lungetransplantation eller lungevolumenreduktionskirurgi (LVRS).
  9. Malignitet, for hvilken forsøgspersonen har gennemgået resektion, strålebehandling, kemoterapi eller biologiske behandlinger inden for de sidste 5 år. Individer med behandlet basalcellecarcinom blev tilladt.
  10. Kendt luftvejsinfektion eller forværring af KOL i de 4 uger før randomisering.
  11. Kendt overfølsomhed over for antikolinerge lægemidler, laktose, benzalkoniumchlorid (BAC), ethylendiamintetraeddikesyre (EDTA) eller andre komponenter i HandiHaler®- eller Respimat®-inhalationsopløsningssystemet.
  12. Kendt moderat til svær nyreinsufficiens (som vurderet af investigator).
  13. Kendt smalvinklet glaukom.
  14. Kendt signifikant symptomatisk prostatahyperplasi eller blærehalsobstruktion. Forsøgspersoner, hvis symptomer blev kontrolleret under behandling, kan have været inkluderet.
  15. Anvendelse af systemisk kortikosteroidmedicin ved ustabile doser (dvs. mindre end 6 uger ved stabil dosis) eller ved doser, der overstiger, hvad der svarer til 10 mg prednisolon pr. dag.
  16. Gravide eller ammende kvinder eller kvinder i den fødedygtige alder, der ikke har brugt en medicinsk godkendt præventionsmiddel i mindst 3 måneder forud for og under forsøgets varighed.
  17. Betydeligt alkohol- eller stofmisbrug inden for de seneste 12 måneder.
  18. Forsøgspersoner, der kræver brug af supplerende iltbehandling i > 12 timer om dagen.
  19. Forsøgspersoner, der havde gennemført et lungerehabiliteringsprogram i de 6 uger forud for screeningsbesøget, eller forsøgspersoner, der i øjeblikket var i et lungerehabiliteringsprogram, der ikke blev opretholdt under hele undersøgelsens varighed.
  20. Forsøgspersoner, der havde taget et forsøgslægemiddel inden for 30 dage før screeningsbesøget.
  21. Tidligere deltagelse (modtagelse af randomiseret behandling) i denne undersøgelse.
  22. Forsøgspersoner, der i øjeblikket deltog i en interventionsundersøgelse.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: BEHANDLING
  • Tildeling: TILFÆLDIGT
  • Interventionel model: PARALLEL
  • Maskning: DOBBELT

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
EKSPERIMENTEL: tiotropium 2,5 mcg og placebo
Patienterne får en af ​​de aktive tiotropium-arme dagligt
Medicin: tiotropium 1,25 mcg (2 aktiveringer/dag)
soft mist inhalator 2 aktiveringer=2 pust/dag
ACTIVE_COMPARATOR: tiotropium 18 mcg og placebo
Patienterne får en af ​​de aktive tiotropium-arme dagligt
Medicin: tiotropium 18 mcg
HandiHaler
EKSPERIMENTEL: tiotropium 5 mcg og placebo
Patienterne får en af ​​de aktive tiotropium-arme dagligt
Medicin: tiotropium 2,5 mcg (2 aktiveringer/dag)
blød tågeinhalator (2 aktiveringer=2 pust/dag)

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Tid til dødelighed af alle årsager
Tidsramme: Op til 3 år
Antal patienter med dødelighed af alle årsager
Op til 3 år
Tid til første KOL-eksacerbation
Tidsramme: Op til 3 år

Defineret som "et kompleks af nedre respiratoriske hændelser/symptomer (stigning i nyopstået) relateret til den underliggende KOL, med varighed på tre dage eller mere, der kræver en ændring i behandlingen", hvor et "kompleks af nedre respiratoriske hændelser/symptomer" var defineret som havende mindst to af følgende: åndenød, opspytproduktion (volumen), forekomst af purulent opspyt, hoste, hvæsende vejrtrækning, trykken for brystet, og hvor "en påkrævet behandlingsændring" omfatter følgende:Receptering af antibiotika og/eller systemisk steroider og/eller en nyligt ordineret vedligeholdelsesmedicin til luftvejene (dvs. bronkodilatatorer inklusive teofylliner).

"Begyndelse af eksacerbation" blev defineret ved begyndelsen af ​​det første registrerede symptom. "Afslutningen af ​​eksacerbation" blev besluttet af investigator baseret på klinisk vurdering.

Eksacerbationer blev klassificeret som følger:

Mild:en ny ordination af kun vedligeholdende bronkodilatator Moderat:antibiotika eller systemiske steroider uden indlæggelse Svær:hospitalisering.
Op til 3 år

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Gennem FEV1 over 120 uger (i en delundersøgelse af 1370 patienter)
Tidsramme: Op til 3 år
Laveste tvungne ekspiratoriske volumen på et sekund (FEV1) over 120 uger (i et delstudie med 1370 patienter)
Op til 3 år
Antal KOL-eksacerbationer
Tidsramme: Op til 3 år
Antallet af KOL-eksacerbationer. KOL-eksacerbation defineret som "et kompleks af hændelser/symptomer i nedre luftveje (forøgelse af nyopstået) relateret til den underliggende KOL, med varighed på tre dage eller mere, der kræver en ændring i behandlingen", hvor et "kompleks af hændelser/symptomer fra nedre luftveje" blev defineret som havende mindst to af følgende: åndenød, opspytproduktion (volumen), forekomst af purulent opspyt, hoste, hvæsende vejrtrækning, trykken for brystet, og hvor "en påkrævet ændring i behandlingen" omfatter følgende:Recept af antibiotika og/ eller systemiske steroider og/eller en nyligt ordineret vedligeholdelsesmedicin til luftvejene (dvs. bronkodilatatorer inklusive teofylliner).
Op til 3 år
Tid til første hospitalsindlæggelse i forbindelse med KOL-eksacerbation
Tidsramme: Op til 3 år
Nedenstående resultater er for patienter med indlæggelser på grund af KOL-eksacerbationer.
Op til 3 år
Antal indlæggelser i forbindelse med KOL-eksacerbation
Tidsramme: Op til 3 år
Samlet antal indlæggelser i forbindelse med KOL-eksacerbation.
Op til 3 år
Tid til første moderat til svær KOL-eksacerbation
Tidsramme: Op til 3 år

KOL-eksacerbation defineret som "et kompleks af hændelser/symptomer i nedre luftveje (forøgelse af nyopstået) relateret til den underliggende KOL, med varighed på tre dage eller mere, der kræver en ændring i behandlingen", hvor et "kompleks af hændelser/symptomer fra nedre luftveje" blev defineret som havende mindst to af følgende: åndenød, opspytproduktion (volumen), forekomst af purulent opspyt, hoste, hvæsende vejrtrækning, trykken for brystet, og hvor "en påkrævet ændring i behandlingen" omfatter følgende:Recept af antibiotika og/ eller systemiske steroider og/eller en nyligt ordineret vedligeholdelsesmedicin til luftvejene (dvs. bronkodilatatorer inklusive teofylliner).

Eksacerbationer klassificeret som følger:

Mild:en ny ordination af kun vedligeholdende bronkodilatator Moderat:antibiotika eller systemiske steroider uden indlæggelse Svær:hospitalisering.

Nedenstående resultater er antallet af patienter med moderate til svære eksacerbationer.
Op til 3 år
Tid til indtræden af ​​den første alvorlige kardiovaskulære hændelse (MACE)
Tidsramme: Op til 3 år
Tid til indtræden af ​​den første alvorlige kardiovaskulære hændelse (MACE). MACE blev defineret som: Dødelig hændelse i systemorganklasserne af hjerte- og karsygdomme, Foretrukne udtryk: pludselig død, hjertedød, pludselig hjertedød, Udfaldsbegivenheder af myokardieinfarkt (alvorlige og ikke-alvorlige), Udfaldsbegivenheder af slagtilfælde (alvorlig og ikke-seriøse) og udfaldsbegivenheder af TIA (alvorlige og ikke-seriøse). Resultaterne nedenfor er for antallet af patienter med MACE.
Op til 3 år
Tid til død af alvorlig kardiovaskulær hændelse (MACE)
Tidsramme: Op til 3 år
Resultaterne præsenteret nedenfor er antallet af patienter med død fra MACE.
Op til 3 år

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Boehringer Ingelheim

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Hjælpsomme links

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. maj 2010

Primær færdiggørelse (FAKTISKE)

1. maj 2013

Studieafslutning (FAKTISKE)

1. maj 2013

Datoer for studieregistrering

Først indsendt

6. maj 2010

Først indsendt, der opfyldte QC-kriterier

18. maj 2010

Først opslået (SKØN)

19. maj 2010

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (SKØN)

20. juni 2014

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. maj 2014

Sidst verificeret

1. maj 2014

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 205.452
  • 2009-015713-51 (EUDRACT_NUMBER: EudraCT)

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med tiotropium 1,25 mcg (2 aktiveringer/dag)

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Iran

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

3
Abonner